# EDGAR Filing Document

**Accession Number:** 0000836690
**File Stem:** 0001104659-23-022001
**Filing Date:** 2023-2
**Character Count:** 136066
**Document Hash:** de4ace7f11cce42b039b81b74d01d257
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-23-022001.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001104659-23-022001

**CONFORMED SUBMISSION TYPE**: PRE 14A

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20230413

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INNOVATIVE SOLUTIONS & SUPPORT INC
- **CENTRAL INDEX KEY:** 0000836690
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **IRS NUMBER:** 232507402
- **STATE OF INCORPORATION:** PA
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** PRE 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41503
- **FILM NUMBER:** 23631948

**BUSINESS ADDRESS:**
- **STREET 1:** 720 PENNSYLVANIA DRIVE
- **CITY:** EXTON
- **STATE:** PA
- **ZIP:** 19341
- **BUSINESS PHONE:** 610 646 9800

**MAIL ADDRESS:**
- **STREET 1:** 720 PENNSYLVANIA DRIVE
- **CITY:** EXTON
- **STATE:** PA
- **ZIP:** 19341

[**TABLE OF CONTENTS**](#TOC)

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No.)

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☒

Preliminary Proxy Statement

☐

**Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))** 

☐

Definitive Proxy Statement

☐

Definitive Additional Materials

☐

Soliciting Material under §240.14a-12

### INNOVATIVE SOLUTIONS AND SUPPORT, INC.
(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒

No fee required.

☐

Fee paid previously with preliminary materials.

☐

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.

------

[**TABLE OF CONTENTS**](#TOC)

#### INNOVATIVE SOLUTIONS AND SUPPORT, INC. 720 Pennsylvania Drive Exton, Pennsylvania 19341 610-646-9800

#### NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
Dear Shareholder:

You are invited to attend the Annual Meeting of Shareholders of Innovative Solutions and Support, Inc. (the "<u>Company</u>"). This year's Annual Meeting will be held in a virtual meeting format only. In order to attend the virtual Annual Meeting at www.virtualshareholdermeeting.com/ISSC2023, you must enter the control number found on your proxy card or voting instruction form. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. You may still vote by telephone, via the Internet, or by mailing a completed proxy card. All references to attending the meeting "in person" or voting "in person" in this Proxy Statement shall refer to attending the virtual meeting "via the hosting website" or voting "via the hosting website." You will not be able to attend the Annual Meeting in person.

**Date:** April 13, 2023

**Time:** 10:00 a.m., Eastern Daylight Time

**Location:** Virtual annual meeting of shareholders conducted via live audio webcast at: www.virtualshareholdermeeting.com/ISSC2023.

#### Purposes of the Meeting:
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **1.**

To approve an amendment to the Amended and Restated Articles of Incorporation of the Company (the "Charter") in order to amend and restate Section (B)(1)(b) of Article FOURTH of the Charter so as to use a majority, rather than super majority, voting standard and to reduce the list of actions for which a shareholder vote is required;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **2.**

To elect six (6) directors to hold office until the annual meeting of shareholders in 2024, or until their respective successors have been duly elected and qualified;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **3.**

To ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2023;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **4.**

To hold a non-binding advisory vote on the frequency of the say-on-pay vote with respect to compensation of the Company's named executive officers;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **5.**

To hold a non-binding advisory vote on named executive officer compensation as disclosed in the Proxy Statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **6.**

To transact any other business that may properly come before the meeting.

#### Record Date:
February 13, 2023, is the record date for the meeting. This means that holders of the Company's common stock at the close of business on that date are entitled to receive notice of the meeting and vote at the meeting and any adjournment or postponement of the meeting.

In the event that the meeting is adjourned for one or more periods totaling at least 15 days due to the fact that there is not a proper quorum, the shareholders entitled to vote who attend the adjourned meeting, even if there is not a proper quorum, shall constitute a quorum for the purpose of acting upon any of the named matters above.

The Company considers your vote important and encourages you to vote as soon as possible.

/s/ SHAHRAM ASKARPOUR

 *President and Chief Executive Officer*, 2023

------

[**TABLE OF CONTENTS**](#TOC)

#### INNOVATIVE SOLUTIONS AND SUPPORT, INC. 720 Pennsylvania Drive Exton, Pennsylvania 19341 610-646-9800

#### **TABLE OF CONTENTS**

---

| | |
|:---|:---|
| | **Page**  |
| [ABOUT THE MEETING](#tATM)  | [1](#tATM) |
| [SECURITY OWNERSHIP OF PRINCIPAL SHAREHOLDERS](#tSOOP)  | [5](#tSOOP) |
| [SECURITY OWNERSHIP OF MANAGEMENT](#tSOOM)  | [5](#tSOOM) |
| [EQUITY COMPENSATION PLAN INFORMATION](#tECPI)  | [6](#tECPI) |
|  [PROPOSAL NO. 1 – PROPOSED AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY](#tPANY)  | [8](#tPANY) |
| [PROPOSAL NO. 2 – ELECTION OF DIRECTORS](#tPN1E)  | [9](#tPN1E) |
| [DIRECTORS AND NOMINEES](#tDAN)  | [9](#tDAN) |
| [INDEPENDENCE](#tIND)  | [11](#tIND) |
| [BOARD LEADERSHIP](#tBOLE)  | [12](#tBOLE) |
| [RISK OVERSIGHT](#tRIOV)  | [12](#tRIOV) |
| [COMMITTEES OF THE BOARD OF DIRECTORS](#tCOTB)  | [12](#tCOTB) |
| [MEETINGS AND ATTENDANCE](#tMAA)  | [15](#tMAA) |
|  [PROPOSAL NO. 3 – RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM](#tPN2R)  | [16](#tPN2R) |
| [REPORT OF THE AUDIT COMMITTEE](#tROTA)  | [18](#tROTA) |
| [RELATED PARTY TRANSACTIONS](#tRPT)  | [20](#tRPT) |
| [REPORT OF THE COMPENSATION COMMITTEE](#tROTC)  | [22](#tROTC) |
|  [PROPOSAL NO. 4 – ADVISORY VOTE ON EXECUTIVE COMPENSATION (SAY-ON-FREQUENCY)](#tPN3A)  | [23](#tPN3A) |
| [PROPOSAL NO. 5 – ADVISORY VOTE ON EXECUTIVE COMPENSATION (SAY-ON-PAY)](#tEXCO)  | [24](#tEXCO) |
| [EXECUTIVE COMPENSATION](#tTIVE)  | [25](#tTIVE) |
| [SUMMARY COMPENSATION TABLE](#tSCT)  | [31](#tSCT) |
| [GRANTS OF PLAN-BASED AWARDS](#tGOPA)  | [31](#tGOPA) |
| [OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END](#tOEAA)  | [32](#tOEAA) |
| [OPTION EXERCISES AND STOCK VESTED](#tOEAS)  | [32](#tOEAS) |
| [POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL](#tPPUT)  | [32](#tPPUT) |
| [SHAREHOLDER PROPOSALS FOR 2024 ANNUAL MEETING AND OTHER MATTERS](#tSPF2)  | [34](#tSPF2) |

---

i

------

[**TABLE OF CONTENTS**](#TOC)

#### INNOVATIVE SOLUTIONS AND SUPPORT, INC. 720 Pennsylvania Drive Exton, Pennsylvania 19341 610-646-9800

#### PROXY STATEMENT for Annual Meeting of Shareholders April 13, 2023
The Board of Directors (the "<u>Board</u>") of Innovative Solutions and Support, Inc. (the "<u>Company</u>") is soliciting your proxy to vote your shares at the Company's 2023 annual meeting of shareholders (the "<u>Annual Meeting</u>"). The Annual Meeting will be held on April 13, 2023 at 10:00 a.m., Eastern Daylight Time and will be conducted on the Internet in a virtual meeting format only. You will be able to participate online and submit your questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/ISSC2023. You will not be able to attend the Annual Meeting in person.

On or about , 2023, the Company will mail to its shareholders of record as of February 13, 2023, the record date for the Annual Meeting, a copy of this Proxy Statement, including the Notice of Annual Meeting of Shareholders (the "<u>Notice</u>") and the Proxy Card, as well as the Company's Annual Report on Form 10-K for the fiscal year ended September 30, 2022 (the "<u>Annual Report</u>"). Please carefully review the Proxy Statement for information on the matters to be presented at the Annual Meeting and for instructions on how to vote your shares. Our Annual Report, including financial statements for such period, does not constitute any part of the material for the solicitation of proxies, but copies are available to shareholders upon request.

#### ABOUT THE MEETING

#### Your vote is important.
You may revoke this proxy at any time before it is voted by written notice to the Company's Secretary and Chief Financial Officer, Michael Linacre, by submission of a proxy bearing a later date, or by casting a ballot at the Annual Meeting. Properly executed and delivered proxies that are received before the Annual Meeting's adjournment will be voted in accordance with the directions provided or, if no directions are provided, will be voted by one of the individuals named on your proxy card, as recommended by the Board. If you wish to give a proxy to someone other than those named on the proxy card, you should cross out those names and insert the name(s) of the person(s), not more than three, to whom you wish to give your proxy.

If you want to vote in during the virtual Annual Meeting and you hold shares of Company common stock in "street name," you must obtain a proxy card from your broker, together with a copy of a brokerage statement reflecting your common stock ownership as of the record date, and provide it in order to access the Annual Meeting.

#### Who can vote?
Shareholders of record at the close of business on February 13, 2023, the record date for the Annual Meeting, are entitled to notice of and to vote at the Annual Meeting. On February 13, 2023, 17,398,808 shares of Company common stock were outstanding and entitled to vote. The Company does not have any other classes of voting stock outstanding other than Company common stock. Each share of common stock is entitled to one vote, and there are no cumulative voting rights when voting for directors. A list of shareholders eligible to vote will be available at the offices of Innovative Solutions and Support, Inc., 720 Pennsylvania Drive, Exton, Pennsylvania 19341 beginning , 2023. Shareholders may examine this list during normal business hours for any purpose relating to the Annual Meeting.

If you and other residents at your mailing address own shares of common stock in "street name," your broker or bank may have notified you that your household will receive only one Annual Report and Proxy Statement, for each company in which you hold stock through that broker or bank. This practice is known as

------

[**TABLE OF CONTENTS**](#TOC)

"house-holding." Unless you responded that you did not want to participate in "house-holding," you were deemed to have consented to the process. Each shareholder will continue to receive a separate proxy card or voting instruction card.

If you did not receive an individual copy of this year's Proxy Statement or Annual Report, the Company will send a copy to you if you address a written request to the Company's Secretary and Chief Financial Officer, Michael Linacre, 720 Pennsylvania Drive, Exton, Pennsylvania 19341, telephone (610) 646-9800.

If you would like to receive your own set of the Company's future annual reports, proxy statements and other annual disclosure documents, or if you share an address with another Company shareholder and, together, both of you would like to receive only a single set of such documents, you should contact your broker or bank, or you may contact the Company at the above address and phone number.

#### What constitutes a quorum?
The presence at the Annual Meeting, in person (i.e., virtually) or by proxy, of shareholders entitled to cast at least a majority of the votes that all shareholders are entitled to cast on a particular matter to be acted upon at the meeting shall constitute a quorum for the purpose of consideration and action on the matter. Abstentions from voting and broker "non-votes" (described below) will be counted toward a quorum. A broker "non-vote" occurs when the nominee holding a shareholder's shares does not vote on a particular proposal because the nominee does not have discretionary voting power on that item and has not received instructions from the shareholder.

#### What vote is required and what is the method of calculation?
In accordance with the Company's Amended and Restated Bylaws, as amended (the "<u>Amended and Restated Bylaws</u>") an affirmative vote of a majority of the votes properly cast at the Annual Meeting is required for approval of all proposals other than Proposal No. 1 (the Charter amendment proposal), which under our Charter must be approved by sixty-five percent (65%) of the Company's issued and outstanding shares. As a result, abstentions or broker "non-votes" will be counted as votes against Proposal No. 1. Abstentions or broker "non-votes" will not be counted for or against any of the other proposals to be voted upon at the Annual Meeting.

#### What is the difference between a routine and a non-routine matter?
Matters to be voted upon at the Annual Meeting are either routine or non-routine matters. The following proposal is considered a routine matter:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2023 (Proposal No. 3).

A broker or other nominee may generally vote in their discretion on routine matters, and therefore no broker "non-votes" are expected in connection with Proposal No. 3.

The following proposals are considered "non-routine" matters:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Approval of amendment to the Amended and Restated Articles of Incorporation of the Company (the "Charter") in order to amend and restate Section (B)(1)(b) of Article FOURTH of the Charter so as to use a majority, rather than super majority, voting standard and to reduce the list of actions for which a shareholder vote is required (Proposal No. 1);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Election of six (6) directors to hold office until the annual meeting of shareholders in 2024, or until their respective successors have been duly elected and qualified (Proposal No. 2);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Non-binding advisory vote on the frequency of the say-on-pay vote with respect to compensation of the Company's named executive officers (Proposal No. 4); and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Non-binding advisory vote on named executive officer compensation as disclosed in the Proxy Statement (Proposal No. 5).

------

[**TABLE OF CONTENTS**](#TOC)

If the organization that holds your shares does not receive instructions from you on how to vote your shares on a non-routine matter, that organization will inform the inspector of election that it does not have the authority to vote on the matter with respect to your shares. This is generally referred to as a "broker non-vote." Therefore, broker "non-votes" may exist in connection with Proposal No. 2, Proposal No. 4, Proposal No. 5, and Proposal No. 1.

#### What matters will be voted on?
The Board does not intend to bring any other matters before the Annual Meeting except the matters listed in the Notice of Annual Meeting of Shareholders, and the Board is not aware of anyone else who will submit any other matters to be voted on. However, if any other matters are properly submitted before the Annual Meeting to be voted on, the people named on the proxy card, or their substitutes, will be authorized to vote on those matters in their own judgment.

#### How do I vote by proxy?
Most shareholders have three ways to vote by proxy: by telephone, by the Internet, or by return of the proxy card. To vote by telephone or by the Internet, you must follow the instructions set forth on the Notice that you receive. To vote by mail, you must sign and date each proxy card you receive, mark the boxes indicating how you wish to vote, and return the proxy card. Do not return the proxy card if you vote by telephone or by the Internet.

#### Can I change my vote after I return my proxy card?
Yes. You can change or revoke your proxy at any time before the Annual Meeting either by notifying the Company's Secretary and Chief Financial Officer in writing or by sending another executed proxy card dated later than the first proxy card. Your attendance at the Annual Meeting will not cause your previously granted proxy to be revoked unless you specifically so request. For shares of common stock that you hold beneficially, you may change or revoke your proxy by submitting new voting instructions to your broker or nominee.

#### Can I vote at the Annual Meeting instead of voting by proxy?
Yes. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. You may still vote by telephone, via the Internet, or by mailing a completed proxy card. However, the Company encourages you to vote by proxy to ensure that your shares of common stock are represented and voted. If you attend the Annual Meeting in person (i.e., virtually), you may then change your vote at the Annual Meeting even though you returned your proxy card.

#### Who pays for this proxy solicitation?
The Company will pay all costs in connection with the Annual Meeting, including the cost of preparing, assembling, and mailing the Notice, Proxy Statement, and proxy card, as well as handling and tabulating the proxies returned. In addition to the use of mail, proxies may be solicited by directors, officers, and employees of the Company, without additional compensation, in person or by telephone or other electronic means. The Company will reimburse brokerage houses and other nominees for their expenses in forwarding proxy material to beneficial owners of the Company's common stock.

#### Who can help answer your questions?
If you have questions about the Annual Meeting or would like additional copies of this Proxy Statement, you should contact the Company's Secretary and Chief Financial Officer, Michael Linacre, 720 Pennsylvania Drive, Exton, Pennsylvania 19341, telephone (610) 646-9800. If you encounter any difficulties accessing the virtual Annual Meeting during the check-in or meeting time, please call 800-586-1548 (Toll Free) or 303-562-9288 for assistance. Technical support will be available beginning at 9:45 a.m., Eastern Time on April 13, 2023 through the conclusion of the Annual Meeting.

------

[**TABLE OF CONTENTS**](#TOC)

#### Annual Report
On written request, the Company will provide, without charge, a copy of its Annual Report (including a list briefly describing the exhibits thereto), filed with the SEC, to any record holder or beneficial owner of its common stock on February 13, 2023, the record date, or to any person who subsequently becomes such a record holder or beneficial owner. Requests should be directed to the attention of the Company's Secretary and Chief Financial Officer at the address set forth above.

------

[**TABLE OF CONTENTS**](#TOC)

#### SECURITY OWNERSHIP OF PRINCIPAL SHAREHOLDERS
The following table sets forth certain information with respect to the beneficial ownership, as of February 13, 2023, of each person whom the Company knew to be the beneficial owner of more than 5% of its common stock. To the knowledge of the Company, each of the shareholders named below has sole or shared power to vote or direct the vote of such shares of common stock or the sole or shared investment power with respect to such shares of common stock, unless otherwise indicated. The information provided in the table is based on the Company's records, information filed with the SEC and information provided to the Company.

---

| | | |
|:---|:---|:---|
| | **Common Stock**  | **Common Stock**  |
| **Name of Beneficial Owner**  | **Number of <br> Shares**  | **Percent of <br> Class<sup>(1)</sup>**  |
| Estate of Geoffrey S. M. Hedrick<sup>(2)</sup>  | 3535567 | 20.4% |
| Christopher Harborne<sup>(3)</sup>  | 2366969 | 13.6% |
| Wealth Trust Axiom, LLC<sup>(4)</sup>  | 1157040 | 6.7% |
| Norman H. Pessin<sup>(5)</sup>  | 861825 | 5.0% |
| Central Square Management LLC<sup>(6)</sup>  | 875417 | 5.0% |

---

(1) As used in this table, beneficial ownership means the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have beneficial ownership of any security that such person has the right to acquire within 60 days after such date. Percentage ownership is based upon 17,398,808 shares of common stock outstanding as of February 13, 2023.

(2) With the exception of 408 shares owned by Mr. Hedrick's spouse, these shares were owned by Mr. Hedrick, the Company's former Chief Executive Officer, whose address was c/o Innovative Solutions and Support, Inc., 720 Pennsylvania Drive, Exton, PA 19341, prior to his passing on January 12, 2022. 3,006,107 of such shares were held by Mr. Hedrick individually and the remaining shares are held in Trusts for the benefit of relatives of Mr. Hedrick. Current ownership information is based solely on Schedule 13D filed on December 28, 2022.

(3) Based solely on Schedule 13G/A filed on September 23, 2022. Christopher Harborne's address is 23F M Thai Tower, All Seasons Place, 87 Wireless Road, Bangkok 10300 Thailand.

(4) Based solely on Schedule 13G/A filed on February 3, 2022. WealthTrust Axiom LLC's address is 550 Swedesford Road, Suite 110, Wayne, PA 19087.

(5) Based solely on Schedule 13D/A filed on September 12, 2022. Norman H. Pessin's address is 400 East 51<sup>st</sup>, PH 31, New York, NY 10022.

(6) Based solely on Schedule 13G/A filed on September 10, 2014. Central Square Management LLC's address is 1813 N. Mill Street, Suite F, Naperville, IL 60563.

#### SECURITY OWNERSHIP OF MANAGEMENT
The following table sets forth certain information with respect to the beneficial ownership, as of February 13, 2023, of (i) each director, (ii) the chief executive officer, the chief financial officer and the Company's other executive officers during the fiscal year ended September 30, 2022, and (iii) all the directors and executive officers as a group. Unless otherwise indicated, each of the shareholders named below has sole voting and investment power with respect to such shares, and the address of each of the shareholders named below is c/o Innovative Solutions and Support, Inc., 720 Pennsylvania Drive, Exton, Pennsylvania 19341. The information provided in the table is based on the Company's records, information filed with the Securities and Exchange Commission, and information provided to the Company.

------

[**TABLE OF CONTENTS**](#TOC)

---

| | | |
|:---|:---|:---|
| | **Common Stock**  | **Common Stock**  |
| **Name of Beneficial Owner**  | **Number of <br> Shares**  | **Percent of <br> Class<sup>(1)</sup>**  |
| Shahram Askarpour  | 217458 | 1.3% |
| Glen R. Bressner  | 68332 | \* |
| Roger A. Carolin<sup>(2)</sup>  | 44180 | \* |
| Winston J. Churchill  | 14130 | \* |
| Stephen L Belland  | 3551 | \* |
| Parizad Olver  | 3196 | \* |
| All executive officers and directors as a group (6 persons)  | 350847 | 2% |

---

\*

Less than 1%.

(1) As used in this table, beneficial ownership means the sole or shared power to vote or direct the voting of a security, or the sole or shared investment power with respect to a security (i.e., the power to dispose, or direct the disposition, of a security). A person is deemed as of any date to have beneficial ownership of any security that such person has the right to acquire within 60 days after such date. Percentage ownership is based upon 17,398,808 shares of common stock outstanding as of February 13, 2023.

(2) Shares are held jointly with Mr. Carolin's wife. Mr. Carolin's address is 7 Great Valley Parkway, Suite 190, Malvern, PA 19355.

#### EQUITY COMPENSATION PLAN INFORMATION
The following table provides information about Company common stock that may be issued upon the exercise of options and pursuant to other awards under all of the Company's existing equity compensation plans and arrangements as of September 30, 2022, including the 2019 Stock-Based Incentive Compensation Plan (the "<u>2019 Plan</u>").

---

| | | | |
|:---|:---|:---|:---|
| **Plan Category**  | **Number of securities to <br> be issued upon exercise <br> of outstanding options, <br> warrants, and rights**  | **Weighted-average <br> exercise price of <br> outstanding options, <br> warrants, and rights**  | **Number of securities <br> remaining available for <br> future issuance under <br> equity compensation <br> plans (excluding <br> securities reflected in the <br> first column)**  |
|  Equity compensation plans approved by security holders  | 57584 | $7.10 | 628824 |
|  Equity compensation plans not approved by security holders  |  |  |  |
| Total  | 57584 | $7.10 | 628824 |

---

In the fiscal years ended September 30, 2022, 2021 and 2020, awards were granted to the Company's non-employee directors under the Company's then-existing equity compensation plans and arrangements with respect to 19,047, 27,488 and 73,056 shares, respectively.

#### 2019 Stock-Based Incentive Compensation Plan
The 2019 Plan was approved by the Company's shareholders at the Company's Annual Meeting of Shareholders held on April 2, 2019. The 2019 Plan authorizes the grant of stock appreciation rights, restricted stock, options and other equity-based awards. Options granted under the 2019 Plan may be either "incentive stock options" as defined in Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the "<u>Code</u>"), or nonqualified stock options, as determined by the Compensation Committee of the Company's Board of Directors (the "<u>Compensation Committee</u>").

Subject to an adjustment necessary upon a stock dividend, recapitalization, forward split or reverse split, reorganization, merger, consolidation, spin-off, combination, repurchase or share exchange,

------

[**TABLE OF CONTENTS**](#TOC)

extraordinary or unusual cash distribution, or similar corporate transaction or event, the maximum number of shares of common stock available for awards under the 2019 Plan is 750,000, plus 139,691 shares of common stock that were authorized but unissued under the Company's 2009 Stock-Based Incentive Compensation Plan as of the effective date of the 2019 Plan (i.e., April 2, 2019), all of which may be issued pursuant to awards of incentive stock options. In addition, the 2019 Plan provides that no more than 300,000 shares may be awarded in any calendar year to any employee. As of September 30, 2022, there were 628,824 shares of common stock available for awards under the 2019 Plan.

If any award is forfeited, terminates or otherwise is settled for any reason without an actual distribution of shares to the participant, the related shares of common stock subject to such award will again be available for future grant. Any shares tendered by a participant in payment of the exercise price of an option or the tax liability with respect to an award (including, in any case, shares withheld from any such award) will not be available for future grant under the 2019 Plan. If there is any change in the Company's corporate capitalization, the Compensation Committee must proportionately and equitably adjust the number and kind of shares of common stock which may be issued in connection with future awards, the number and kind of shares of common stock covered by awards then outstanding under the 2019 Plan, the aggregate number and kind of shares of common stock available under the 2019 Plan, any applicable individual limits on the number of shares of common stock available for awards under the 2019 Plan, the exercise or grant price of any award, or if deemed appropriate, make provision for a cash payment with respect to any outstanding award. In addition, the Compensation Committee may make adjustments in the terms and conditions of any awards, including any performance goals, in recognition of unusual or nonrecurring events affecting the Company or any subsidiary, or in response to changes in applicable laws, regulations, or accounting principles.

The 2019 Plan will terminate on April 2, 2029, unless earlier terminated by the Board. Termination will not affect awards outstanding at the time of termination. The Board may amend, alter, suspend, discontinue, or terminate the 2019 Plan without shareholder approval, provided that shareholder approval is required for any amendment which (i) would increase the number of shares subject to the 2019 Plan; (ii) would decrease the price at which awards may be granted; or (iii) would require shareholder approval by law, regulation, or the rules of any stock exchange or automated quotation system.

------

[**TABLE OF CONTENTS**](#TOC)

#### PROPOSAL NO. 1 — PROPOSED AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION OF THE COMPANY

#### (Item 1 on Proxy Card)
The Company's shareholders are being asked to vote upon and approve an amendment to the Company's Amended and Restated Articles of Incorporation (the "<u>Charter</u>") to amend and restate Section (B)(1)(b) of Article FOURTH of the Charter ("<u>Section (B)(1)(b)</u>") as follows:

**Current Language**:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b) <u>Super Majority Voting</u>. Notwithstanding anything herein contained to the contrary, the affirmative vote of the holders of not less than sixty-five percent (65%) of the Series A Preferred Stock and Common Stock then issued and outstanding and voting as a single class shall be required for: (i) any merger, consolidation or sale of all or substantially all of the assets of the Corporation; (ii) any acquisition of the capital stock of another entity as a result of which such entity's financial results of operations are required by generally accepted accounting principles to be consolidated with the financial results of operations of the Corporation, or the acquisition of all or substantially all of the assets of another entity; (iii) any issuance by the Corporation of non-trade funded indebtedness or the issuance by the Corporation of capital stock for a consideration per share which is less than the fair market value of the capital stock as determined in good faith by the Board of Directors; (iv) any amendment to the Corporation's Articles of Incorporation, as amended after the date hereof; and (v) the authorization by the Corporation of a class or Series of capital stock having rights and preferences which are pari passu with or superior to the rights and preferences of the Series A Preferred Stock.

#### Proposed Language :
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b) <u>Majority Voting</u>. Notwithstanding anything herein contained to the contrary, the affirmative vote of the holders of a majority of the Common Stock then issued and outstanding shall be required for: (i) any merger, consolidation or other sale of the Corporation; (ii) any issuance by the Corporation of common stock, other than a public offering for cash, which possesses voting power equal to or in excess of 20% of the voting power outstanding before such issuance; (iii) any issuance by the Corporation of capital stock for a consideration per share which is less than the fair market value of the capital stock as determined in good faith by the Board of Directors; (iv) any amendment to the Corporation's Articles of Incorporation, as amended after the date hereof; and (v) the authorization by the Corporation of a class or Series of capital stock having rights and preferences which are pari passu with or superior to the rights and preferences of the Series A Preferred Stock.

These changes are being proposed to provide the Board with more flexibility to exercise its business judgment to evaluate and pursue future opportunities in the Company's growth and development. The current version of Section (B)(1)(b) was adopted prior to the Company's initial public offering on August 4, 2000, but no longer fits the Company's operating structure, business, or status as a publicly traded company, because its rigid and outdated structure creates unnecessary delays and impediments to the Company's ability to take actions for the benefit of its shareholders. Accordingly, the Board has approved and deemed advisable, and is recommending that shareholders approve, the amendment to its Charter to amend and restate Section (B)(1)(b) in its entirety.

 **The Board of Directors recommends a vote "FOR" approval of the amendment to the Company's Amended and Restated Articles of Incorporation to amend and restate Section (B)(1)(b).** 

------

[**TABLE OF CONTENTS**](#TOC)

#### PROPOSAL NO. 2 — ELECTION OF DIRECTORS

#### (Item 2 on Proxy Card)
At the Annual Meeting, the shareholders will elect six (6) directors to hold office until the annual meeting of shareholders in 2024, or until their respective successors have been duly elected and qualified.

Upon the recommendation of the Nominating & Corporate Governance Committee of the Board (the "<u>Nominating & Corporate Governance Committee</u>"), the Board has nominated Messrs. Shahram Askarpour, Winston J. Churchill, Roger A. Carolin, Glen R. Bressner and Stephen L. Belland and Ms. Parizad Olver (Parchi) to serve as directors. Each of the foregoing persons currently serves as a director, and each has indicated a willingness to continue to serve as a director.

Unless contrary instructions are given, the shares represented by a properly executed proxy will be voted "**FOR**" the elections of each of the nominees. Shareholders must cast a separate vote "**FOR**" the candidacy of each nominee or to "**WITHHOLD AUTHORITY**" with respect thereto. Each nominee must receive a majority of the votes cast to be elected. Should any nominee become unavailable to accept election as a director, the persons named in the enclosed proxy will vote the shares that they represent for the election of such other person as the Board may recommend. **The Board of Directors recommends voting "FOR" the nominees for directors**.

#### DIRECTORS AND NOMINEES
The members of the Board as of the date of the Annual Meeting, including the nominees for directors standing for election at this meeting, together with certain information about them, are set forth below.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name**  | **Age**  | **Director <br> Since**  | **Current <br> Term Expires**  | **Positions with the Company**  |
| Shahram Askarpour  | 65 | 2022 | 2023 | Director, Chief Executive Officer  |
| Winston J. Churchill  | 82 | 1990 | 2023 | Director |
| Roger A. Carolin  | 67 | 2016 | 2023 | Director |
| Glen R. Bressner  | 62 | 1999 | 2023 | Director |
| Stephen L. Belland  | 65 | 2022 | 2023 | Director |
| Parizad Olver (Parchi)  | 43 | 2022 | 2023 | Director |

---

#### Directors and Nominees
*Shahram Askarpour.* Dr. Askarpour joined the Company as Vice President of Engineering in 2003, was promoted to President in March 2012, and was appointed as the Company's Chief Executive Officer, and joined the Company's Board, in January 2022. Dr. Askarpour has more than 40 years of aerospace industry experience in managerial and technical positions. Prior to joining the Company, he was employed by Smiths Aerospace (a division of Smiths Group plc), Instrumentation Technology, and Marconi Avionics. He holds a number of key patents in the aviation field. Dr. Askarpour received his engineering education in the United Kingdom, and received an undergraduate degree in Electrical Engineering from Middlesex University, a post graduate Certificate of Advanced Study in Systems Engineering, and a PhD in Automatic Control from Brunel University London. He was awarded the title of Associate Research Fellow for three consecutive years by Brunel University and has published numerous papers in leading international, peer reviewed journals. In addition, he has completed management courses at Carnegie Mellon University and finance courses at the Wharton School of the University of Pennsylvania.

*Winston J. Churchill.* Mr. Churchill has been managing general partner of SCP Partners, a multi-stage venture capital firm that invests in technology-oriented companies, since he founded it in 1996, and has over 35 years of experience in private equity investing. He formed Churchill Investment Partners, Inc. in 1989 and CIP Capital, L.P., a small business investment company, in 1990. Prior to that, he was a managing partner of a private investment firm that specialized in leveraged buyouts on behalf of Bessemer Securities Corporation. From 1967 to 1983, he practiced law at the Philadelphia firm of Saul Ewing Arnstein & Lehr, LLP and served as Chairman of its Banking and Financial Institutions Department, Chairman of the

------

[**TABLE OF CONTENTS**](#TOC)

Finance Committee, and a member of its Executive Committee. He has experience serving as a director of other public companies, including Amkor Technology, Inc. (NASDAQ: AMKR), Recro Pharma, Inc. (NASDAQ: REPH), and formerly Griffin Industrial Realty Inc. (NASDAQ: GRIF), as well as a number of private companies. From 1989 to 1993, he served as Chairman of the Finance Committee of the Pennsylvania Public School Employees' Retirement System. He is currently a Trustee Fellow of Fordham University, Chairman of Young Scholars Charter School, Chairman Emeritus of The Gesu School, and a trustee of American Friends of New College Oxford, England; for many years, he was also a trustee of Georgetown University, where he chaired the Committee on Medical Affairs. He earned a Bachelor of Science in Physics, summa cum laude, from Fordham University, a Master of Arts in Economics from Oxford University, where he studied as a Rhodes Scholar, and a Juris Doctor from Yale Law School.

*Roger A. Carolin.* Mr. Carolin is currently a Venture Partner at SCP Partners, a position he has held since 2004. Mr. Carolin works to identify attractive investment opportunities and assists portfolio companies in the areas of strategy development, operating management, and intellectual property. Mr. Carolin co-founded CFM Technologies, Inc., a global manufacturer of semiconductor process equipment, and served as its Chief Executive Officer for 10 years, until the company was acquired. Mr. Carolin formerly worked for Honeywell, Inc. and General Electric Co., where he developed test equipment and advanced computer systems for on-board missile applications. Mr. Carolin is also a director of Amkor Technology, Inc. (NASDAQ: AMKR), a supplier of outsourced semiconductor assembly and test services. Mr. Carolin holds a B.S. in Electrical Engineering from Duke University and an M.B.A. from the Harvard Business School.

*Glen R. Bressner.* Mr. Bressner has been a venture capitalist since 1985 and is co-Founder and Managing Partner of NEPA Venture Funds, Mid-Atlantic Venture Funds, Originate Ventures and Activate Venture Partners. He is also a shareholder and a director on the board of Alum-a-Lift, Inc., a family-owned manufacturer of material handling solutions. From 1996 to 1997, Mr. Bressner served as the Chairman of the Board of the Greater Philadelphia Venture Group. Mr. Bressner holds a Bachelor of Science, cum laude, in Business Administration from Boston University and a Masters of Business Administration degree from Babson College.

*Stephen L. Belland.* Mr. Belland is the Co-Founder and Chief Executive Officer at Integrated Connection, LLC and a Principal at Clear Rock Advisors. Prior to Clear Rock Advisors, he has held various executive positions at Rockwell Collins including Technical Director, Vice President of Program and Product Management, Vice President of Strategy and Marketing and most recently Vice President of Corporate Development. Mr. Belland received his B.S. in Electrical Engineering from Michigan Technological University and has attended executive programs at the Kellogg School of Management, the Wharton School of the University of Pennsylvania, and INSEAD.

*Parizad Olver (Parchi).* Ms. Olver is currently the Founder and Managing Partner of Panorama Aero, a U.S.-based special mission aerospace lessor and end-to-end logistics provider which she founded in 2018. Ms. Olver also serves as Independent Director and Chair of the Audit Committee of Semper Paratus Acquisition Corporation (NASDAQ: LGST). From 2009-2018, Ms. Olver held numerous leadership positions during her time at Cowen Inc., including President and CEO of Cowen Aviation Finance, Head of International Strategy and Managing Director. Prior to Cowen, Ms. Olver held senior positions at Fortress Investment Group, Ramius Capital Group and Morgan Stanley. She received an M.B.A. from Columbia University, an M.B.A. from London Business School and a B.S. from University of California, Berkeley (Haas School of Business).

#### Director Qualifications
The Board believes that each of the directors and the nominees for director listed above have the sound character, integrity, judgment, and record of achievement necessary to be a member of the Board. In addition, each of the directors and the nominees for director have exhibited, during their prior service as directors, the ability to operate cohesively with the other members of the Board, and to challenge and question management in a constructive way. Moreover, the Board believes that each director and the nominees for director bring a strong and unique background and skillset to the Board, giving the Board, as a whole, competence and experience in diverse areas, including corporate governance and board service, finance,

------

[**TABLE OF CONTENTS**](#TOC)

management, and aviation. Set forth below are certain specific experiences, qualifications, and skills that led to the Board's conclusion that each of the directors and the nominees for director listed above should continue to serve as a directors.

Dr. Askarpour, as Chief Executive Officer of the Company and a longstanding member of the Company's management team, provides the Board with a comprehensive knowledge of the Company, its history, and its businesses. In addition, Dr. Askarpour brings the Board his insight into the aerospace industry from over 40 years of experience in managerial and technical positions at aviation companies, including Smiths Aerospace (a division of Smiths Group plc), Instrumentation Technology, and Marconi Avionics.

Mr. Churchill brings the Board over 35 years of experience in private equity investing, during which he gained valuable insight into effective management of investments. Mr. Churchill utilizes this insight to advise the Board on financial and investment matters. In addition, Mr. Churchill has extensive experience serving on the boards of directors of other companies, both public and private. Mr. Churchill draws on his financial and corporate governance experience in his service on the Investment Committee of the Board (the "<u>Investment Committee</u>") (as Chairman), the Nominating & Corporate Governance Committee, and the Audit Committee of the Board (the "<u>Audit Committee</u>"). In addition, Mr. Churchill has maintained a pilot's license for over fifteen years and has Instrument and Multi-Engine ratings. Consequently, he brings to the Board operational experience with state-of-the-art avionics.

Mr. Carolin has over a decade of experience in private equity investing, previously worked in advanced computer systems and on-board missile applications, and has a significant understanding the Company's industry and its business. He possesses specific knowledge and experience in technology, new business opportunities, operations, management, and finance, all of which are relevant and important to the Company's business, and he capitalizes on these strengths in his service on the Compensation Committee (as Chairman) and the Audit Committee.

Mr. Bressner brings the Board a wealth of experience managing financial investments from his service at venture capital firms. Mr. Bressner provides the Board with a thorough understanding of capital markets and other financial issues. Mr. Bressner's experience in managing investments also provides him with extensive finance and accounting knowledge, and he applies this expertise in his service on the Audit Committee (as Chairman), the Investment Committee and the Nominating & Corporate Governance Committee. Mr. Bressner is also an audit committee financial expert, as defined by SEC rules and regulations. His prior service as Chairman of the Board of Directors of the Greater Philadelphia Venture Group and on numerous other boards of directors, including of several public entities, provides him with valuable experience in corporate governance matters.

Mr. Belland has over 37 years of experience in the Aerospace and Defense Industry. Mr. Belland provides the board with familiarity with IS&S product lines and operations. He has also developed numerous successful plans for market strategy, product development, brand management, business optimization, acquisition strategy, as well as team building strategy. Some key successes included developing and capturing over 15 new aircraft cockpit positions, as well as positioning his corporation for becoming a leader in business jet cabin electronics. In addition, Mr. Belland has advised on over 500 M&A transactions and joint ventures, including being published in Corporate Executive Board materials. Mr. Belland is also a private pilot and a member of various industry organizations, such as the National Business Aviation Association.

Ms. Olver brings over two decades of experience in financial markets and investing across special situations and aerospace related assets. She has a background in aviation, as well as experience with special mission operations which will strengthen the Board. She is currently a board member of Samper Paratus Acquisition Corp., a $350 million public company specializing in logistics/transportation, and SMASS, Inc. a U.S. government subcontractor focusing on U.S. Army logistics support. She is also a term member alumnus of the Council on Foreign Relations.

#### INDEPENDENCE
The Board has determined, in its business judgment, that five (5) of the Company's six (6) directors are independent as defined in the applicable Nasdaq Stock Market, LLC ("<u>NASDAQ</u>") listing standards, including that each member is free of any relationships that would interfere with his individual exercise of

------

[**TABLE OF CONTENTS**](#TOC)

independent judgment. The following directors were determined to be independent: Glen R. Bressner, Winston J. Churchill, Roger A. Carolin, Stephen L. Belland, and Parizad Olver (Parchi).

#### BOARD LEADERSHIP
The Board does not have a formal policy on whether the roles of Chief Executive Officer and Chairman of the Board should be separate. Currently, Dr. Shahram Askarpour serves as the Company's Chief Executive Officer and Mr. Winston J. Churchill serves as the Chairman of the Company' Board. The Board believes that this leadership structure is in the best interests of the Company's shareholders as it promotes information flow between management and the Board, effective decision making, and an alignment of corporate strategy.

The Board also believes that its structural features, including that all of its members other than Dr. Askarpour, and all members of its key committees, are independent directors, provide for substantial independent oversight of the Company's management. However, the Board recognizes that other leadership models may become more appropriate as circumstances change.

#### RISK OVERSIGHT
The Company faces a number of risks, including technological and intellectual property risk, regulatory risk, credit risk, liquidity risk, reputational risk, and risk from adverse fluctuations in interest rates. Management is responsible for the day-to-day management of risks faced by the Company, while the Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, the Board seeks to ensure that the risk management processes designed and implemented by management are adequate. The Board consults periodically with management regarding the Company's risks.

While the Board is ultimately responsible for risk oversight, the Company's board committees assist the Board in fulfilling its oversight responsibilities in certain areas of risk. The Audit Committee assists the Board in its oversight of risk management in the areas of financial reporting and internal controls. The Compensation Committee assists the Board in oversight of risks related to the Company's compensation policies and programs. The Investment Committee assists the Board in oversight of the risks related to the Company's cash investments and utilization of capital. The Nominating & Corporate Governance Committee assists the Board in oversight of risk associated with board organization, membership and structure, succession planning for directors and executive officers, and corporate governance.

#### COMMITTEES OF THE BOARD OF DIRECTORS
The Board maintains four standing committees: Audit, Compensation, Investment, and Nominating & Corporate Governance.

*Audit Committee.* The Audit Committee makes recommendations to the Board with respect to various auditing and accounting matters, including the selection and compensation of the Company's independent registered public accounting firm, the scope of the Company's annual audits, fees to be paid to the independent registered public accounting firm, the performance and independence of the Company's independent registered public accounting firm, and the Company's accounting practices.

The Audit Committee approves all services provided to the Company by the independent registered public accounting firm. The Audit Committee has established procedures for the receipt, retention, and treatment, on a confidential basis, of complaints received by the Company regarding accounting, internal accounting controls, or auditing matters, and the confidential, anonymous submissions by employees of concerns regarding questionable accounting or auditing matters. In addition, the Audit Committee has responsibility for, among other things, the planning and review of the Company's annual and periodic reports and accounts, and the involvement of the Company's independent registered public accounting firm in that process. The members of the Audit Committee are currently Mr. Bressner (Chairman), Mr. Carolin, and Ms. Olver. The Audit Committee is comprised solely of independent members, as independence for audit committee members is defined by the applicable NASDAQ listing standards. In addition, the Board has determined, in its business judgment, that each member of the Audit Committee is financially literate, and

------

[**TABLE OF CONTENTS**](#TOC)

that Messrs. Bressner and Carolin and Ms. Olver are all audit committee financial experts, as defined by SEC rules and regulations. The Audit Committee has adopted a formal written charter that has been approved by the Board. The charter specifies the scope of the Audit Committee's responsibilities and procedures for carrying out such responsibilities. A copy of the charter is available on the Company's website, www.innovative-ss.com, under the heading "Investor Relations."

*Compensation Committee.* The Compensation Committee is responsible for setting and administering the policies that govern all executive compensation decisions, including annual base salaries, bonuses, and equity-based compensation programs. The Compensation Committee evaluates annually the performance of the Company's Chief Executive Officer and determines or recommends to the full Board the annual base salary, bonus, and equity-based compensation for the Chief Executive Officer. The Compensation Committee relies on the recommendations of the Chief Executive Officer, following the Chief Executive Officer's annual performance reviews of other executive officers, in setting annual base salaries, bonuses, and equity-based compensation for other executive officers.

The Compensation Committee is also responsible for reviewing and overseeing the Company's benefit plans, equity incentive plans, and other compensation plans and policies for employees, consultants, directors, and other compensated individuals, including the Chief Executive Officer. The members of the Compensation Committee are currently Messrs. Carolin (Chairman), Churchill, and Belland, each of whom, in the judgment of the Board, was found to be "independent" as defined by the applicable NASDAQ listing standards. The Compensation Committee has adopted a formal written charter that has been approved by the Board. The charter specifies the scope of the Compensation Committee's responsibilities and procedures for carrying out such responsibilities. A copy of the charter is available on the Company's website, www.innovative-ss.com, under the heading "Investor Relations."

The Compensation Committee has the authority under its charter to engage the services of outside consultants, advisors, and others to assist the Compensation Committee, and in 2022, engaged Frederic W. Cook & Co., Inc. ("<u>FW Cook</u>") for this purpose, as further described in the "*Process for Setting Total Compensation*" section. The Compensation Committee determines the appropriate levels of compensation for executive officers taking into account, among other factors, the market comparison and other data and analyses provided by FW Cook, the performance of the executive officers in question (as determined in annual reviews conducted by the Compensation Committee for the Chief Executive Officer or by the Chief Executive Officer for the other executive officers), the Company's financial performance, cost of living, prior compensation practices, and recruitment and retention needs. The Compensation Committee relies on the recommendations of the Company's Chief Executive Officer in determining whether and how much of a discretionary bonus may be paid to the Company's employees (including executive officers other than the Chief Executive Officer) if the Company's financial performance exceeds the Board's expectations.

*Compensation Committee Interlocks and Insider Participation.* No member of the Compensation Committee is a former or current executive officer or employee of the Company. There are no compensation committee interlocks between the Company and any other entity involving the Company or such entity's executive officers or board members.

*Investment Committee.* The Investment Committee assists the Board in fulfilling its oversight responsibilities with respect to recommendations pertaining to the utilization of excess capital, including with respect to the implementation of the Company's stock repurchase program. Messrs. Churchill (Chairman), Carolin, and Belland are currently the members of the Investment Committee.

*Nominating & Corporate Governance Committee.* The Nominating & Corporate Governance Committee's functions include establishing the criteria for selecting candidates for nomination to the Board, seeking candidates who meet those criteria, making recommendations to the Board of nominees to fill vacancies on or as additions to the Board, and monitoring the Company's corporate governance structure. The Nominating & Corporate Governance Committee members are currently Messrs. Churchill and Bressner, each of whom, in the judgment of the Board, was found to be "independent" as defined by the applicable NASDAQ listing standards. The Nominating & Corporate Governance Committee has adopted a formal written charter that has been approved by the Board. The charter specifies the scope of the Nominating & Corporate Governance Committee's responsibilities and procedures for carrying out such responsibilities. A copy of the charter is available on the Company's website, www.innovative-ss.com, under the heading "Investor Relations."

------

[**TABLE OF CONTENTS**](#TOC)

The Nominating & Corporate Governance Committee seeks director candidates based upon a number of qualifications and criteria, including independence, knowledge, judgment, character, leadership skills, education, experience, financial literacy, standing in the community, the ability to foster a diversity of backgrounds and views, and the ability to complement the Board's existing strengths relative to the Company's business. In the case of potential independent director candidates, such eligibility criteria must be in accordance with SEC and NASDAQ rules. While the Nominating & Corporate Governance Committee does not have a formal policy with regard to the consideration of diversity in identifying director nominees, the Nominating & Corporate Governance Committee and the Board believe that it is essential that the Board be able to draw on a wide variety of backgrounds and professional experience among its members. The Nominating & Corporate Governance Committee desires to maintain the Board's diversity through the consideration of factors such as education, skills, and relevant professional experience and to identify the best possible nominees for the Board, regardless of a nominee's self-identified age, race, religion, national origin, sex, sexual orientation, disability or any other basis proscribed by law.

The Nominating & Corporate Governance Committee will consider nominees for election to the Board who are timely recommended by shareholders, provided that a complete description of the nominees' qualifications, experience, and background, together with a statement signed by each nominee in which he or she consents to act as such, accompany the recommendations. Such recommendations should be submitted in writing to the attention of Chairman, Nominating & Corporate Governance Committee, at the Company's address at 720 Pennsylvania Drive, Exton, PA, 19341, and should not include self-nominations. Section 3.10 of the Company's Amended and Restated Bylaws contains provisions setting forth the requirements applicable to a shareholder nomination for director. These requirements are summarized in this Proxy Statement under the caption "Shareholder Proposals for 2023 Annual Meeting and other Matters."

Each of the current nominees for director listed under the caption "ELECTION OF DIRECTORS" is an existing director standing for re-election. In connection with the Annual Meeting, the Nominating & Corporate Governance Committee did not receive any recommendation for a candidate from any shareholder or group of shareholders owning more than 5% of the Company's common stock.

The Annual Meeting provides an opportunity each year for shareholders to ask questions of or otherwise communicate directly with members of the Company's Board on matters relevant to the Company. Per Company policy, each director is requested to attend the Annual Meeting in person (i.e., virtually). All five of the Company's then-serving directors attended the Company's 2022 Annual Meeting of Shareholders.

In addition, shareholders may communicate with the Board, or if applicable, to a specific individual director, by sending a written communication to the attention of the Board or such individual director at the following address: 720 Pennsylvania Drive, Exton, PA, 19341, or by facsimile to (610) 646-0150.

Copies of each written communication received at such address or facsimile number will be provided to the Board or to the specific individual director, unless such communication is considered, in the reasonable judgment of the Corporate Secretary or other appropriate company officer, to be improper for submission to the intended recipient. Examples of shareholder communications that would be considered improper for submission include, without limitation, customer complaints, solicitations, communications that do not relate directly or indirectly to the Company or the Company's business, or communications that relate to improper or irrelevant topics.

The Nominating & Corporate Governance Committee conducts an annual assessment of the size and composition of the Board and its committees and reviews with the Board the appropriate skills and characteristics required of Board members. The Nominating & Corporate Governance Committee has not relied upon third-party search firms to identify board candidates, but reserves the right to do so as required. To date, the Nominating & Corporate Governance Committee has relied upon recommendations from a wide variety of its business contacts, including current executive officers, directors, community leaders, and shareholders as a source for potential board candidates.

Neither the Nominating & Corporate Governance Committee nor the Company has engaged or paid any fees to a search firm in connection with the nomination of the directors for election at the Annual Meeting covered by this Proxy Statement.

------

[**TABLE OF CONTENTS**](#TOC)

#### MEETINGS AND ATTENDANCE
During the fiscal year ended September 30, 2022, the full Board held 13 meetings. From time to time during fiscal year 2022 the Board met in executive session without members of management present. The Audit Committee met 4 times, and the Investment Committee, the Compensation Committee, and the Nominating & Corporate Governance Committee met once each. All of our directors attended, and are expected to attend, at least 75% of the meetings of the full Board and the meetings of the committees on which they served.

------

[**TABLE OF CONTENTS**](#TOC)

#### PROPOSAL NO. 3 — RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

#### (Item 3 on Proxy Card)
The Company has retained Grant Thornton LLP ("<u>Grant Thornton</u>") as the independent registered public accounting firm to audit the Company's consolidated financial statements for the fiscal year ending September 30, 2023. Although action by the shareholders on these matters are not required, the Audit Committee and the Board believe it is appropriate to seek shareholder ratification of this selection in light of the role played by the independent registered public accounting firm in reporting on the Company's consolidated financial statements. Ratification requires the affirmative vote of a majority of eligible shares present at the Annual Meeting, in person (i.e., virtually) or by proxy, and voting thereon. If this appointment is not ratified by the shareholders, the Audit Committee may reconsider its selection.

One or more representatives of Grant Thornton are expected to attend the Annual Meeting. Representatives of Grant Thornton will have an opportunity to make a statement if they desire to do so and will be available to respond to appropriate questions.

#### Principal Accountant Fees and Services
Services provided by Grant Thornton for the fiscal years ended September 30, 2022 and 2021 have included audits of the annual consolidated financial statements of the Company, audits of the effectiveness of internal controls over financial reporting as required by the Sarbanes-Oxley Act of 2002, as amended ("<u>Sarbanes-Oxley</u>"), and other services related to filings made with the SEC. The aggregate fees billed by Grant Thornton in connection with services rendered during the fiscal years ended September 30, 2022 and 2021, respectively, were:

---

| | | |
|:---|:---|:---|
| | **Grant Thornton <br> FY 2022**  | **Grant Thornton <br> FY 2021**  |
| Audit Fees  | $394275 | $373275 |
| Audit Related Fees  | 15750 |  |
| Tax Fees  |  |  |
| Total  | $410025 | $373275 |

---

#### Audit Fees
Audit fees for fiscal years 2022 and 2021 were for professional services rendered for the audit of the Company's annual consolidated financial statements, auditing the effectiveness of the Company's internal controls over financial reporting, review of the interim consolidated financial statements included in quarterly reports, and services that are normally provided by Grant Thornton in connection with statutory and regulatory filings or engagements.

#### Audit Related Fees
Audit-related fees were paid to Grant Thornton during fiscal year 2022 for services provided in the filing of the Company's Registration Statement on Form S-3.

#### Tax-Related Fees
No tax-related fees were paid to Grant Thornton during fiscal years 2022 or 2021.

#### All Other Fees
No other fees were incurred in connection with services provided by Grant Thornton during fiscal years 2022 or 2021.

 *Pre-Approved Policies and Procedures* 

The Audit Committee's policy is to pre-approve the engagement of accountants to render all audit and tax-related services for the Company and any changes to the terms of the engagement. The Audit Committee

------

[**TABLE OF CONTENTS**](#TOC)

pre-approves all proposed non-audit related services to be provided by the Company's independent registered public accounting firm. The Audit Committee reviews the terms of the engagement and a description of the services along with a fee proposal for the engagement. If agreed to by the Audit Committee, the Audit Committee formally accepts the engagement letter and fee proposal. Any proposal by the Company's independent registered public accounting firm for non-audit services must be specific as to the particular services to be provided. Management and the independent registered public accounting firm must each confirm to the Compensation Committee that each proposed non-audit and non-audit related service is permissible under all applicable legal requirements. Requests can be submitted to the Audit Committee and approved in one of the following ways: by a request for approval of services at a meeting of the Audit Committee, or through a written request to the Audit Committee, which may be approved by a written consent by the Audit Committee or by a designated member of the Audit Committee. The Audit Committee approved all 2022 and 2021 fees paid to Grant Thornton.

Pursuant to the adoption of the Audit Committee Charter (as revised), the Board has adopted a policy which prohibits the Company from entering into non-audit related consulting agreements for financial information systems design and implementation, for certain other services considered to have an impact on independence, and for all other services prohibited by Sarbanes-Oxley and SEC regulations. The policy also contains procedures requiring Audit Committee pre-approval of all audit and permitted non-audit services provided by the Company's independent registered public accounting firm.

#### The Board of Directors recommends a vote "FOR" ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm.

------

[**TABLE OF CONTENTS**](#TOC)

#### REPORT OF THE AUDIT COMMITTEE
 *The following report of the Audit Committee will not be deemed incorporated by reference by any general statement incorporating by reference this Proxy Statement into any filing under the Securities Act of 1933, as amended, or under the Exchange Act, except to the extent that the Company specifically incorporates this information by reference. The following report shall not otherwise be deemed filed under such Acts.* 

The Audit Committee assists the Board in its oversight of the financial reporting process. The Audit Committee operates pursuant to a charter. As set forth in the charter, management of the Company is responsible for the preparation, presentation and integrity of its financial statements, accounting and financial reporting principles, and internal controls and procedures designed to assure compliance with accounting standards and applicable laws and regulations. The Company's independent registered public accounting firm is responsible for auditing the Company's financial statements and expressing an opinion as to their conformity with generally accepted accounting principles in the United States of America ("<u>GAAP</u>"), and for reviewing the Company's unaudited interim financial statements. The Audit Committee reviews and reassesses the adequacy of its charter on an annual basis. It is not the Audit Committee's duty or responsibility to conduct auditing or accounting reviews or procedures. However, the Audit Committee will take the appropriate actions to set an overall corporate "standard" for quality financial reporting, sound business risk practices, and ethical behavior.

The Audit Committee makes recommendations to the Board with respect to the selection and compensation of the Company's independent registered public accounting firm, the scope of the annual audits, and the fees to be paid to the independent registered public accounting firm. In connection with the decision regarding whether to re-appoint the independent auditor each year (subject to shareholder ratification), the Audit Committee conducts an annual assessment of the independent auditor's performance, including, but not limited to, assessing the independent auditor's qualifications and experience, the communication and interactions with the auditor over the course of the previous year, and the auditor's independence, objectivity, and professional skepticism. In addition, the Audit Committee monitors the performance and independence of the Company's independent registered public accounting firm and approves all services provided to the Company by the independent registered public accounting firm. The Audit Committee consults with and reviews recommendations made by the independent registered public accounting firm with respect to financial statements, financial records, and financial controls of the Company. The Audit Committee meets with management periodically to consider the adequacy of the Company's internal controls and discusses with management the Company's disclosure controls and procedures.

The Board, in its business judgment, has determined that each of the directors on the Audit Committee is independent as required by Rule 5605(c)(2)(A) of the listing standards of the NASDAQ. In addition, the Board has determined, in its business judgment, that each member of the Audit Committee is financially literate, and that at least one of the Audit Committee members, Mr. Bressner, is an audit committee financial expert, as defined by SEC rules and regulations.

In the performance of its oversight function of the Company's overall financial reporting process and the financial statements for the 2022 fiscal year, the Audit Committee has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • reviewed and discussed the Company's audited financial statements for the year ending September 30, 2022 with management and with the independent registered public accounting firm for the fiscal year ending September 30, 2022, Grant Thornton;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • discussed with Grant Thornton the overall scope and plans for its 2022 audit, and met with representatives of the firm, both with and without management present, to discuss the results of its examination, its evaluation of the Company's internal controls, and the overall quality of the Company's financial reporting;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • reviewed and discussed management's report on internal control over financial reporting in accordance with Section 404 of Sarbanes-Oxley;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • discussed with Grant Thornton the matters required to be discussed by Statement on Auditing Standards No. 26, as amended, "Communication With Audit Committees" (AICPA, Professional Standards, Vol. 1. AU section 380), as adopted by the Public Company Accounting Oversight Board

------

[**TABLE OF CONTENTS**](#TOC)

in Rule 3200T, relating to the conduct of the audit, its judgment as to the quality, not just the acceptability of the Company's accounting principles; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • received written disclosures and the letter from Grant Thornton regarding its independence, as required by applicable requirements of the Public Company Accounting Oversight Board. All audit services provided by Grant Thornton to the Company, and related fees in fiscal year 2022 were pre-approved by the Audit Committee.

Based upon the review, reports, and discussions described in this report, and subject to the limitations on the role and responsibilities of the Audit Committee referred to above and in the charter, the Audit Committee recommended to the Board that the audited financial statements for the fiscal year ended September 30, 2022 be included in the Annual Report, as filed with the Securities and Exchange Commission.

Submitted by the Audit Committee:

Glen R. Bressner (Chairman)

Roger A Carolin

Parizad Olver (Parchi)

------

[**TABLE OF CONTENTS**](#TOC)

#### RELATED PARTY TRANSACTIONS
The charter of the Audit Committee provides that it is the responsibility of the Audit Committee to review and approve any transaction between the Company and its officers, directors, and 5% shareholders.

#### Compensation of Directors
The Company's compensation program for non-employee directors consists of three elements of compensation: meeting fees, restricted stock or restricted stock unit awards, and an annual retainer. Each non-employee director is entitled to a fee of $1,500 for each Board meeting attended and $1,500 for each committee meeting that is not held on the same day as a Board meeting. Mr. Bressner, in his role as Chairman of the Audit Committee, receives $12,000 per year in addition to the meeting fees and restricted stock or restricted stock unit awards. Each non-employee director is also paid an annual retainer of $25,000. In addition, Mr. Churchill, Chairman of the Board, is paid a non-employee annual retainer of $10,000.

The Company also makes annual awards of restricted stock or restricted stock units, with each such unit representing a contingent right to receive one share of common stock upon vesting, to non-employee directors under the 2019 Plan. The target value of such annual awards is $40,000 for each non-employee director. The number of shares underlying such annual awards are calculated based upon the price of the Company's common stock at the close of business on the first business day of each calendar year and such shares vest on the last business day of such calendar year. A director who resigns during the course of the year will vest in and receive a pro rata portion of the shares that he or she otherwise would have vested (in the case of restricted stock) or received (in the case of restricted stock units) had no such resignation occurred, based on the number of days served during the applicable calendar year.

With respect to the fiscal year ended September 30, 2022, the Company's common stock closed at a price of $6.57 per share on January 3, 2022. Accordingly, each non-employee director who continuously served on the Board through December 31, 2022 received 6,088 shares of fully vested common stock of the Company on January 3, 2023 for service provided during the calendar year ended December 31, 2022, and Mr. Belland and Ms. Olver, who served on the Board continuously from their respective dates of appointment to the Board through December 31, 2022, received pro rated share amounts (3,551 and 3,196, respectively) for their service provided during the calendar year ended December 31, 2022.

In addition, all directors are reimbursed for reasonable travel and lodging expenses actually incurred in connection with required attendance at Board and committee meetings.

 *Director Compensation Table* 

The following table provides information on the total compensation earned by each non-employee director of the Company for the fiscal year ended September 30, 2022:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name**  | **Fees Earned <br> or Paid in <br> Cash <br> $<sup>(1)</sup>**  | **Stock <br> Awards <br> $<sup>(2)</sup>**  | **Option <br> Awards <br> $**  | **Non-Equity <br> Incentive Plan <br> Compensation <br> $**  | **Change in <br> Pension Value <br> and <br> Non-qualified <br> Deferred <br> Compensation <br> Earnings**  | **All Other <br> Compensation <br> $<sup>(3)</sup>**  | **Total <br> $**  |
| Glen R. Bressner  | 29000 | 40000 |  |  |  | 14583 | 83583 |
| Winston J. Churchill  | 20000 | 40000 |  |  |  | 20416 | 80416 |
| Robert E. Mittelstaedt, Jr.  | 12500 | 53329 |  |  |  | 14117 | 79946 |
| Roger A. Carolin  | 20000 | 40000 |  |  |  | 14583 | 74583 |
| Stephen L. Belland  | 4500 |  |  |  |  | 8333 | 12833 |
| Parizad Olver (Parchi)  | 6000 |  |  |  |  | 6875 | 12875 |

---

(1) The amounts reported in this column include fees paid for attendance of Board and Board committee meetings.

------

[**TABLE OF CONTENTS**](#TOC)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

(2) The amounts reported in this column represent the grant date fair value, computed based on the compensation cost recognized for financial reporting purposes by the Company in accordance with the valuation guidelines of Accounting Standards Codification ("<u>ASC</u>") 505-50, "*Equity-Based Payments to Non-Employees*" and ASC 718 "*Compensation — Stock Compensation*" with respect to the stock awards granted to each non-employee director during the fiscal year ended September 30, 2022. See also Note 3, under the heading "Share-Based Compensation," to the Company's audited financial statements as filed in the Annual Report, which sets forth the material assumptions used in determining the compensation cost to the Company with respect to such awards. In addition, as of the close of the fiscal year ended September 30, 2022, none of the non-employee directors held outstanding options to purchase stock of the Company.

(3) Amounts reported in this column represent the annual retainer for each non-employee director for the year ended September 30, 2022.

#### Code of Ethics
The Company maintains a Code of Business Conduct and Ethics (the "<u>Code of Ethics</u>") applicable to its directors, its principal executive officer and principal financial and accounting officer, and persons performing similar functions. In addition, the Code of Ethics applies to all of the Company's employees, officers, agents, and representatives. The Code of Ethics is posted on the Company's website, www.innovative-ss.com, under the heading "Investor Relations."

#### Anti-Hedging and Anti-Pledging Policies
The Company maintains an Insider Trading Policy which prohibits Company employees, directors and related parties from engaging in hedging transactions absent prior approval from the Chief Compliance Officer. The Insider Trading Policy also prohibits Company employees, directors and related parties from purchasing Company securities on margin, holding Company securities in a margin account or pledging Company securities.

#### Executive Officers
Set forth below is a table identifying the Company's current executive officers who are not identified in the tables above. Biographical information for Dr. Askarpour is set forth above.

---

| | | |
|:---|:---|:---|
| **Name**  | **Age**  | **Position with the Company**  |
| Shahram Askarpour | 64  | President and Chief Executive Officer |
| Michael Linacre | 46  | Chief Financial Officer |

---

*Michael Linacre.* Mr. Linacre began his career at KPMG LLP as a public accountant. He subsequently held finance leadership positions at Genpak, LLC, a food service packaging company, and SI Group, Inc., a chemical manufacturing company, before serving as the Chief Financial Officer of Sysco Albany, LLC, a subsidiary of Sysco Corporation (NYSE: SYY), and of Crisafulli Bros. Plumbing & Heating Contractors, Inc., a provider of plumbing, sewer and drain, heating and cooling design, installation and maintenance services. Mr. Linacre is a licensed certified public accountant ("<u>CPA</u>") and a member of the American Institute of CPAs and the New York State Society of CPAs. He attended the State University of New York at Albany.

------

[**TABLE OF CONTENTS**](#TOC)

#### REPORT OF THE COMPENSATION COMMITTEE
The Compensation Committee has reviewed and discussed the Compensation Discussion and Analysis section of the Company's Proxy Statement with management, and based on the Compensation Committee's review and discussion with management, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis section be included in the Company's Proxy Statement for fiscal year 2022.

Submitted by the Compensation Committee:

Roger A. Carolin (Chairman)

Winston J. Churchill

Stephen L. Belland

------

[**TABLE OF CONTENTS**](#TOC)

#### PROPOSAL NO. 4 — ADVISORY VOTE ON EXECUTIVE COMPENSATION (SAY-ON-FREQUENCY)

#### (Item 4 on Proxy Card)
In accordance with the Dodd-Frank Act and Section 14A of the Exchange Act, the Company is seeking the input of its shareholders on the frequency with which it will hold a non-binding advisory vote on the compensation of its named executive officers in the future. In voting on this Item 4, shareholders may indicate their preference as to whether the advisory vote on the compensation of the Company's named executive officers should occur (a) once every three years, (b) once every two years or (c) once every year. The Company currently holds such a vote once every three years.

It is the opinion of the Board that the frequency of the shareholder vote on the compensation of the Company's named executive officers should continue to be once every three years. The Company views the way it compensates its named executive officers as an essential part of its strategy to maximize the performance of the Company and deliver enhanced value to the Company's shareholders. The Board believes that continuing the practice of holding such a vote every three years will permit the Company to focus on developing compensation practices that are in the best long-term interests of its shareholders, while simultaneously giving shareholders the time frame they need to fully evaluate the design and effectiveness of those practices. The Board believes that a more frequent advisory vote could have the unintended consequence of causing the Company to focus on the short-term impact of its compensation practices to the possible detriment of the long-term performance of the Company.

The Board believes that an advisory vote on named executive officer compensation is the most effective way for shareholders to communicate with the Company about its compensation objectives, policies and practices, and it looks forward to receiving the input of the Company's shareholders on the frequency with which such a vote should be held in the future. Although the results of this vote may impact how frequently the Company holds an advisory vote on executive compensation, this vote is not binding on the Company. The Board may decide, after considering the results of this vote, that it is in the best interests of the Company's shareholders to hold the advisory vote on executive compensation on a different schedule than the option approved by the Company's shareholders.

#### The Board of Directors recommends a vote "FOR" a frequency vote on say-on-pay of once every three years.

------

[**TABLE OF CONTENTS**](#TOC)

#### PROPOSAL NO. 5 — ADVISORY VOTE ON EXECUTIVE COMPENSATION (SAY-ON-PAY)

#### (Item 5 on Proxy Card)
In accordance with the Dodd-Frank Act and Section 14A of the Exchange Act, the Company is providing its shareholders with the opportunity to cast an advisory vote on the compensation of its named executive officers, as disclosed in the "*Executive Compensation*" section and accompanying tables beginning on page [25](#tTIVE) of this Proxy Statement. The Company believes that it is appropriate to seek the views of its shareholders on the design and effectiveness of the Company's executive compensation program.

The Company's goal for its executive compensation is to attract and retain exceptional individuals as executive officers and to provide key executives with motivation to perform to the full extent of their abilities to maximize the performance of the Company and deliver enhanced value to the Company's shareholders. The Company believes that its executive compensation program achieves these goals by (i) providing competitive base salaries, (ii) awarding performance-based cash bonuses and (iii) granting equity-based awards from time to time to its executive officers. For a more detailed description of the Company's financial results for fiscal year 2022, please see "*Management's Discussion and Analysis of Financial Condition and Results of Operations*" in the Company's Annual Report.

The Company believes that the information provided in the "*Executive Compensation*" section of this Proxy Statement demonstrates that our executive compensation program was designed appropriately and is working to ensure that management's interests are aligned with our shareholders' interests to support long-term value creation. Accordingly, we are asking our shareholders to vote "FOR" the following resolution at the Annual Meeting:

"RESOLVED, that the compensation paid to the Company's named executive officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, compensation tables and narrative discussion is hereby APPROVED."

As an advisory vote, this proposal is not binding upon the Company. However, to the extent that a significant percentage of votes are cast against the compensation of the Company's named executive officers, the Company will determine whether any actions are necessary to address the concerns reflected in such votes.

#### The Board of Directors recommends a vote "FOR" the resolution regarding compensation of the Company's named executive officers.

------

[**TABLE OF CONTENTS**](#TOC)

#### EXECUTIVE COMPENSATION

#### Compensation Discussion and Analysis
This Compensation Discussion and Analysis provides an overview of the Company's executive compensation program and a description of the material factors underlying the decisions that resulted in the compensation provided to the Company's President and Chief Executive Officer and Chief Financial Officer for the fiscal year ended September 30, 2022 (referred to herein as our "<u>named executive officers</u>"). The names of the Company's 2022 named executive officers, together with their titles during the 2022 fiscal year, are:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Shahram Askarpour —** President and Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Michael Linacre —** Chief Financial Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Geoffrey S. M. Hedrick —** Chief Executive Officer (Former)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • **Relland M. Winand —** Chief Financial Officer (Former)

Consistent with the SEC's rules, compensation information for Messrs. Hedrick and Winand is included even though Mr. Hedrick passed away on January 12, 2022 and Mr. Winand retired on July 15, 2022, because each of them served as named executive officers for a portion of the 2022 fiscal year.

#### Objective of the Company's Executive Compensation Program
The objective of the Company's executive compensation program is to attract and retain exceptional individuals as executive officers and to provide key executives with motivation to perform to the full extent of their abilities to maximize the performance of the Company and deliver enhanced value to the Company's shareholders.

#### What the Company's Executive Compensation Program is Designed to Reward
Overall, the Company's executive compensation program is designed to reward the contributions of each individual executive officer, to ensure that each executive officer's interest is aligned with those of the Company's shareholders, and to provide sufficient incentives to executive officers to ensure their dedication to the Company. As discussed further below, the Company seeks to achieve these goals by providing sufficient base salaries to compensate executives for the day-to-day performance of their duties and awarding cash bonuses when the executive attains the annual personal or corporate goals and objectives established by the Company. Also, from time to time, the Company grants equity-based awards when it believes that such equity awards will further align the interests of executive officers with those of the Company's shareholders and provide an additional incentive to executive officers to contribute to the achievement of the Company's financial and strategic objectives.

#### General Executive Compensation Policies
 *Process for Setting Total Compensation* 

Generally, upon hiring or promoting a named executive officer, the Compensation Committee sets the executive's initial level of base salary and other compensation on the basis of subjective factors, including experience, individual achievements, and level of responsibility assumed at the Company, and may consider market compensation practices from time to time. Actual base salaries, cash bonuses, and equity-based awards for each named executive officer may be adjusted from year to year based upon each named executive officer's annual review and level of attainment of personal and corporate goals and objectives, including Company financial performance, shareholder return, and such other factors as the Compensation Committee deems appropriate and in the best interests of the Company's shareholders.

Each named executive officer's annual review is a subjective process whereby the Chief Executive Officer or the Compensation Committee (as applicable, as described below) evaluates various factors relevant to the named executive officer's contributions to the Company, such as the executive's role in the development and execution of strategic plans, leadership skills, motivation, and involvement in industry groups. The weight given to such factors may vary from one named executive officer to another.

------

[**TABLE OF CONTENTS**](#TOC)

The Compensation Committee seeks recommendations from the Chief Executive Officer regarding changes to the overall compensation level or any particular element of compensation for the other named executive officers. In addition, the Chief Executive Officer is principally responsible for reviewing each other named executive officer's performance, and for making recommendations for the Company's compensation plan for such executive officer for the following fiscal year. The Compensation Committee reviews the recommendations of the Chief Executive Officer in light of his proximity to the other executives and his knowledge of their contributions to the Company. The Compensation Committee independently reviews the performance of the Company's Chief Executive Officer. With respect to compensation changes for fiscal year 2022, the Compensation Committee completed this process with the Company's former Chief Executive Officer, Mr. Hedrick, prior to Mr. Hedrick's passing.

Historically, the Compensation Committee has not retained an outside consultant or advisor to advise it regarding the Company's executive compensation program. However, in 2022, the Compensation Committee engaged FW Cook to advise the Compensation Committee with respect to best practices and competitive market practices and trends in the area of executive compensation, as well as ongoing regulatory considerations. The Compensation Committee has determined that FW Cook, which does not perform any work for the Company than its services for the Compensation Committee, is independent and that its services do not raise any conflict of interest with the Company or any of the Company's executive officers or directors.

 *Consideration of Shareholder Advisory Vote on Executive Compensation* 

Based upon the vote of the Company's shareholders at the 2017 annual meeting of shareholders, the Company currently provides its shareholders with the opportunity to cast an advisory vote on executive compensation (a "<u>say-on-pay proposal</u>") once every three (3) years. At the Company's annual meeting of shareholders held in 2020, over 98% of the votes cast on the say-on-pay proposal at that meeting were voted in favor of the proposal. The Compensation Committee believes that this voting result affirms shareholders' strong support of the Company's approach to executive compensation and did not materially change its approach in fiscal years 2021 or 2022. The Compensation Committee will consider the outcome of this year's say-on-pay vote (Proposal 4) when making future compensation decisions for the named executive officers. Following this year's vote, the next time the Company is scheduled to hold a say-on-pay vote is at the Company's annual meeting of shareholders to be held in 2026.

#### Elements of Compensation
The Company's executive compensation program consists of the following elements of compensation, each described in greater depth below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Base Salary;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Annual Bonus;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Equity-based Compensation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • Perquisites; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • General Benefits.

In determining the different elements of compensation to provide to the named executive officers, the Compensation Committee does not adhere to a specific allocation between short-term and long-term compensation, or between cash and non-cash compensation. Instead, the Compensation Committee determines the elements of compensation in a manner designed to reward strong financial performance, provide overall compensation opportunities that are sufficient to attract and retain highly skilled named executive officers, and ensure that named executive officers' interests are aligned with those of the Company's shareholders. This may result in the named executive officers receiving all cash compensation in some years (through base salary and annual bonuses) and a combination of cash and equity-based compensation in other years (through base salary, annual bonuses and equity awards).

 *Base Salary* 

The Company pays base salaries to named executive officers because the Company believes that base salaries are essential to recruiting and retaining qualified executives. In addition, base salaries create an

------

[**TABLE OF CONTENTS**](#TOC)

incentive for named executive officers to make meaningful contributions to the Company's success because they are subject to increase based on the executive's performance. The Compensation Committee sets the initial base salary level upon the hire or promotion of a named executive officer. Base salary levels are determined initially based on the named executive officer's previous experience and employment, and the named executive officer's expected duties and responsibilities with respect to the Company. Thereafter, the Compensation Committee may increase a named executive officer's base salary each year based on the results of the named executive officer's annual review (which is conducted by the Chief Executive Officer for each of the other named executive officers and by the Compensation Committee for the Chief Executive Officer), and based on the Compensation Committee's subjective assessment of the Company's overall performance during the preceding year.

 *Annual Bonus* 

The Compensation Committee retains discretion to grant bonus compensation to the named executive officers and other employees of the Company. From time to time, the Company may award discretionary annual bonuses to the named executive officers and may agree, in hiring or promoting a named executive officer, to a target bonus opportunity, expressed as a percentage of base salary, in any case, to be paid only if the Company determines that the Company has attained its financial performance goals or other objectives.

With respect to fiscal year 2022, discretionary bonuses of $300,000 and $25,000 were approved for Dr. Askarpour and Mr. Linacre, respectively.

 *Equity-based Compensation* 

The Company awards equity-based compensation to named executive officers in order to provide a link between the long-term results achieved for its shareholders and the rewards provided to named executive officers, thereby ensuring that such officers have a continuing stake in the Company's long-term success. Historically, equity-based compensation has been provided to named executive officers in the form of stock options (see the section titled "*Equity Compensation Plan Information*" above). Such awards are made at the discretion of the Compensation Committee and are not timed or coordinated with the release of material, non-public information.

In connection with his hiring as the Chief Financial Officer of the Company, on July 15, 2022, Mr. Linacre was granted 7,886 shares of restricted common stock of the Company. The restrictions will lapse with respect to the restricted stock, and the restricted stock will vest, 25% on the first anniversary of the grant date and in equal quarterly installments thereafter, such that 100% will be vested as of the fourth anniversary of the grant date. If Mr. Linacre's employment is terminated for any reason, he will forfeit any unvested portion of the restricted stock, and if Mr. Linacre's employment is terminated for "cause," then he will forfeit the entire award (whether vested or unvested).

No equity awards were granted to any named executive officers, other than Mr. Linacre (as described in the preceding paragraph), during fiscal year 2022.

 *Perquisites* 

In prior years, the Company has, with the approval of each of the then-serving independent directors, permitted the Company's former Chief Executive Officer, Mr. Hedrick, to use the Company's corporate aircraft for personal travel. The Compensation Committee believes that personal use of the Company's aircraft represented a valuable perquisite for the Chief Executive Officer and was appropriate considering Mr. Hedrick's position and contributions to the Company. The aggregate incremental cost to the Company of this perquisite received by Mr. Hedrick during the relevant fiscal year is included in the Summary Compensation Table below. Mr. Hedrick used the Company's corporate aircraft for personal travel during fiscal years 2021 and 2020.

 *General Benefits* 

The following are standard benefits offered to all eligible Company employees, including the named executive officers.

------

[**TABLE OF CONTENTS**](#TOC)

*Retirement Benefits.* The Company maintains a tax-qualified 401(k) savings plan for all eligible employees, including the named executive officers, known as the Innovative Solutions and Support 401(k) Plan (the "<u>Savings Plan</u>"). The Savings Plan is a voluntary contributory plan under which employees may elect to defer compensation for federal income tax purposes under Section 401(k) of the Code. The Company makes a matching contribution to the Savings Plan at one half of each participant's deferral rate, limited to a maximum contribution of 2% of base salary and subject to limitations imposed by the Internal Revenue Code.

*Medical, Dental, Life Insurance, and Disability Coverage.* The Company makes available medical, dental, life insurance, and disability coverage to all active eligible employees, including the named executive officers.

*Other Paid Time-Off Benefits.* The Company provides vacation and other paid holidays to all employees, including the named executive officers.

#### Employment Agreements
It is the Company's general philosophy that all of the Company's employees should be "at will" employees, thereby allowing both the Company and the employee to terminate the employment relationship at any time and without restriction or financial obligation. However, in certain cases, the Company has determined that, as a retention device and a means to obtain non-compete arrangements, employment agreements or other contractual agreements are appropriate.

The Company entered into an amended and restated employment agreement with Dr. Askarpour on April 14, 2022 in connection with his appointment as Chief Executive Officer of the Company on January 14, 2022. The initial term of the employment agreement began on April 14, 2022 and will end on April 13, 2024. Pursuant to the terms of the agreement, the term extends for one additional year each subsequent April 14, unless either party provides written notice to the other party at least 30 days prior to the expiration of the then-current term that the term will not be renewed. The agreement provides for a base salary of $400,000 per year, which the Company determined to be appropriate given Dr. Askarpour's increased duties and responsibilities as Chief Executive Officer. If Dr. Askarpour's employment is terminated by the Company without "cause" or by Dr. Askarpour for "good reason," then, subject to Dr. Askarpour's execution and non-revocation of a release of claims in favor of the Company, the Company will continue to pay Dr. Askarpour his base salary at the rate then in effect for a period of twelve (12) months following his termination date, during which period the Company will also pay Dr. Askarpour's COBRA premiums. The employment agreement contains covenants restricting Dr. Askarpour's ability to compete with the Company or solicit its employees, other service providers, or current, former, or prospective customers for twelve (12) months after the cessation of Dr. Askarpour's employment. The employment agreement also contains standard confidentiality, assignment of invention, and non-disparagement provisions.

The Company entered into an offer letter agreement with Mr. Linacre on June 1, 2022 in connection with his hiring as the Chief Financial Officer of the Company. The offer letter provides for a base salary of $230,000 per year, an annual target bonus amount equal to 30% of his base salary, a grant of restricted common stock of the Company (as described in the section titled "*Equity-based Compensation*" above) and certain relocation benefits. If Mr. Linacre's employment is terminated without "cause," then, subject to Mr. Linacre's execution and non-revocation of a release of claims in favor of the Company, the Company will continue to pay Mr. Linacre his base salary at the rate then in effect for a period of six (6) months following his termination date in addition to a pro-rata bonus for the year of termination based on the actual bonus he would have been paid absent such termination. The offer letter contains covenants restricting Mr. Linacre's ability to compete with the Company or solicit its employees, other service providers, or current, former, or prospective customers for twelve (12) months after the cessation of Mr. Linacre's employment. The offer letter also contains standard confidentiality, assignment of invention, and non-disparagement provisions.

#### Change in Control Benefits
The Compensation Committee has the authority to accelerate the vesting of Company equity awards granted to named executive officers under the Company's 2019 Plan upon a change in control of the

------

[**TABLE OF CONTENTS**](#TOC)

Company (except for certain transactions that are expressly carved out under the 2019 Plan). The Company believes that such accelerated vesting is essential to maintaining the commitment and dedication of its key employees throughout a potential change in control of the Company. Unless otherwise determined by the Compensation Committee or provided in an award agreement, "change in control" is generally defined for these purposes as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the acquisition in one or more transactions during any 12-month period by any "person" (as such term is used for purposes of section 13(d) or section 14(d) of the Exchange Act) but excluding, for this purpose, the Company or its subsidiaries or any employee benefit plan of the Company or its subsidiaries, of "beneficial ownership" (within the meaning of Rule 13d-3 under the Exchange Act) of thirty percent (30%) or more of the combined voting power of the Company's then outstanding voting securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a change in the composition of the Board during any 12-month period such that the individuals who at the beginning of such period constituted the Board cease to constitute a majority of the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the consummation of a merger or consolidation involving the Company, if the shareholders of the Company, immediately before such merger or consolidation, do not own, directly or indirectly, immediately following such merger or consolidation, more than seventy percent (70%) of the combined voting power of the outstanding voting securities of the corporation resulting from such merger or consolidation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a complete liquidation or dissolution of the Company or a sale or other disposition of all or substantially all of the assets of the Company.

Under Dr. Askarpour's amended and restated employment agreement, in the event of a "change in control," if a successor to the Company fails or refuses to either materially assume the Company's obligations under Dr. Askarpour's employment agreement or enter into a new employment agreement with Dr. Askarpour on terms that are materially similar to those provided under his employment agreement, then Dr. Askarpour may terminate his employment with "good reason" and, subject to his execution and non-revocation of a release of claims in favor of the Company, the Company will continue to pay Dr. Askarpour his base salary at the rate then in effect for a period of twelve (12) months following his termination date, during which period the Company will also pay Dr. Askarpour's COBRA premiums. For purposes of Dr. Askarpour's employment agreement, "change in control" is generally defined for these purposes as:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a "person" (as such term is used for purposes of section 13(d) or section 14(d) of the Exchange Act) but excluding, for this purpose, any employee benefit plan of the Company or its subsidiaries, is or becomes a "beneficial owner" (within the meaning of Rule 13d-3 under the Exchange Act) of forty percent (40%) or more of the combined voting power of the Company's then outstanding voting securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a change in the composition of the Board during any 2-year period such that the individuals who at the beginning of such period constituted the Board cease to constitute a majority of the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • the consummation of a merger or consolidation involving the Company, if the shareholders of the Company, immediately before such merger or consolidation, do not own, directly or indirectly, immediately following such merger or consolidation, at least seventy-five percent (75%) of the combined voting power of the outstanding voting securities of the corporation resulting from such merger or consolidation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; • a complete liquidation or dissolution of the Company or a sale or other disposition of all or substantially all of the assets of the Company.

#### Stock Ownership/Retention Requirements
The Company does not require its named executive officers to maintain a minimum ownership interest in the Company.

#### Tax and Accounting Considerations
The Company considers tax and accounting implications in determining all elements of its executive compensation program. Section 162(m) of the Code generally denies a federal income tax deduction for

------

[**TABLE OF CONTENTS**](#TOC)

compensation exceeding $1,000,000 paid in a taxable year to the Chief Executive Officer, the Chief Financial Officer or any of the three highest compensated officers (other than the Chief Executive Officer and Chief Financial Officer). The Compensation Committee considers the impact of this deductibility limitation on the compensation that it intends to award, and may pay compensation that is not deductible if it determines that doing so is in the best interest of the Company and consistent with the Company's executive compensation program. Through September 30, 2022, Section 162(m) of the Code has not affected the Company's tax deductions. At the present time, the Compensation Committee believes that it is unlikely that the compensation paid to any of the Company's employees in a taxable year will exceed $1,000,000.

The Compensation Committee considers the impact of various forms of compensation on the Company's financial results. In particular, the Compensation Committee considers the potential impact on current and future financial results of all equity compensation that it approves.

------

[**TABLE OF CONTENTS**](#TOC)

#### SUMMARY COMPENSATION TABLE
This Summary Compensation Table provides information on the total compensation earned by each named executive officer for fiscal years ended September 30, 2022, 2021 and 2020.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name and Principal Position**  | **Year**  | **Salary <br> $**  | **Bonus <br> $**  | **Option <br> Awards <br> $<sup>(2)</sup>**  | **All Other <br> Compensation <br> $<sup>(1)</sup>**  | **Total <br> $**  |
|  Shahram Askarpour <br> Chief Executive Officer  | 2022 | 369616 | 300000 |  | 6585 | 676201 |
|  Shahram Askarpour <br> Chief Executive Officer  | 2021 | 300000 |  |  | 5700 | 305700 |
|  Shahram Askarpour <br> Chief Executive Officer  | 2020 | 300000 |  |  | 5369 | 305369 |
|  Michael Linacre <br> Chief Financial Officer  | 2022 | 53077 | 25000 |  |  | 78077 |
|  Michael Linacre <br> Chief Financial Officer  |  |  |  |  |  |  |
|  Geoffrey S. M. Hedrick, <br> Former Chief Executive Officer  | 2022 | 123326 |  |  | 817 | 124143 |
|  Geoffrey S. M. Hedrick, <br> Former Chief Executive Officer  | 2021 | 400000 |  |  | 18364 | 418364 |
|  Geoffrey S. M. Hedrick, <br> Former Chief Executive Officer  | 2020 | 400000 |  |  | 8099 | 408099 |
|  Relland Winand <br> Former Chief Financial Officer  | 2022 | 157692 | 100000 | 49023 | 5154 | 311869 |
|  Relland Winand <br> Former Chief Financial Officer  | 2021 | 200000 |  |  | 4000 | 204000 |
|  Relland Winand <br> Former Chief Financial Officer  | 2020 | 200000 |  | 362700 | 4000 | 566700 |

---

(1) The amounts set forth in this column represent only contributions to the respective named executive officer's Savings Plan account for the applicable fiscal year, except that, as described in the Compensation Discussion and Analysis section above, the amounts for Mr. Hedrick, the Company's former Chief Executive officer, include the incremental cost to the Company of permitting personal use of a Company aircraft in fiscal year 2021 ($12,664) and 2020 ($2,757).

(2) These amounts represent the aggregate date fair value determined in accordance with the valuation guidelines of ASC Topic 718 "*Stock Compensation*" with respect to the options granted to Mr. Winand, the Company's former Chief Financial Officer in the applicable year. See also Note 3, under the heading "*Share-Based Compensation*," in the Company's audited financial statements as filed in the Annual Report.

#### GRANTS OF PLAN-BASED AWARDS
The following table sets forth information about non-equity and equity awards granted to the named executive officers in the fiscal year ended September 30, 2022.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name**  | **Grant <br> Dates of <br> Equity <br> Awards**  | **Estimated Future Payout under**  | **Estimated Future Payout under**  | **Estimated Future Payout under**  | **Estimated Future Payout under**  | **Estimated Future Payout under**  | **Estimated Future Payout under**  | **All Other <br> Stock <br> Awards: <br> Number of <br> Shares <br> of Stock <br> or Units**  | **2022 Grant <br> Date Fair <br> Value of <br> Stock and <br> Option <br> Awards <br> ($)**  |
| **Name**  | **Grant <br> Dates of <br> Equity <br> Awards**  | **Minimum <br> ($)**  | **Target <br> ($)**  | **Maximum <br> ($)**  | **Minimum <br> (Shares)**  | **Target <br> (Shares)**  | **Maximum <br> (Shares)**  | **All Other <br> Stock <br> Awards: <br> Number of <br> Shares <br> of Stock <br> or Units**  | **2022 Grant <br> Date Fair <br> Value of <br> Stock and <br> Option <br> Awards <br> ($)**  |
| Shahram Askarpour  |  |  |  |  |  |  |  |  |  |
| Michael Linacre  |  |  |  |  |  |  |  |  |  |
| Geffrey S.M. Hedrick  |  |  |  |  |  |  |  |  |  |
| Relland Winand  |  |  |  |  |  |  |  |  |  |

---

------

[**TABLE OF CONTENTS**](#TOC)

#### OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END
The following table provides outstanding stock option information for the named executive officers as of the end of fiscal year 2022:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Name**  | **Grant Date**  | **Number of <br> Securities <br> Underlying <br> Unexercised <br> Options <br> # Exercisable**  | **Number of <br> Securities <br> Underlying <br> Unexercised <br> Options <br> # Unexercisable**  | **Equity Incentive <br> Plan Awards <br> Number of <br> Securities <br> Underlying <br> Unexercised <br> Unearned <br> Options <br> #**  | **Option <br> Exercise <br> Price<sup>(2)</sup> <br> $**  | **Option <br> Expiration <br> Date**  |
| Shahram Askarpour  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – &nbsp;&nbsp; |  |  |
| Michael Linacre  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – &nbsp;&nbsp; |  |  |
| Geffrey S.M. Hedrick  |  |  |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – &nbsp;&nbsp; |  |  |
| Relland Winand  | 8/27/2020 | 57584 | 57584 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; – &nbsp;&nbsp; | 7.10 | 8/27/2030 |

---

(1) The applicable exercise price of each outstanding option reflects the stock price on date of grant.

#### OPTION EXERCISES AND STOCK VESTED
The following table provides information on the value of stock options that were exercised and stock awards that vested during the fiscal year ended September 30, 2022 for each of our named executive officers:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Option Awards**  | **Option Awards**  | **Stock Awards**  | **Stock Awards**  |
| **Name**  | **Number of <br> Shares Acquired <br> on Exercise**  | **Value <br> Realized on <br> Exercise <br> $**  | **Number of <br> Shares <br> Acquired on <br> Vesting**  | **Value <br> Realized on <br> Vesting <br> ($)**  |
| Shahram Askarpour  |  |  |  |  |
| Michael Linacre  |  |  |  |  |
| Geffrey S.M. Hedrick  |  |  |  |  |
| Relland Winand  |  |  | 50000 |  |

---

#### POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE IN CONTROL
As described in the Compensation Discussion and Analysis section above, Dr. Askarpour's amended and restated employment agreement provides that if his employment is terminated by the Company without "cause" or by Dr. Askarpour for "good reason," then, subject to his execution and non-revocation of a release of claims in favor of the Company, the Company will continue to pay Dr. Askarpour his base salary at the rate then in effect for a period of twelve (12) months following his termination date, during which period the Company will also pay Dr. Askarpour's COBRA premiums. If Dr. Askarpour's employment were terminated by the Company without "cause" or for "good reason" on September 30, 2022, the total amounts payable to Dr. Askarpour would be $213,878. For purposes of Dr. Askarpour's employment agreement, "cause" generally means (a) the commission by or conviction of Dr. Askarpour, or plea of guilty or nolo contendere to, a felony or any crime involving dishonesty, disloyalty, or moral turpitude; (b) Dr. Askarpour's willful misconduct or willful failure substantially to perform the duties of his position or his willful refusal to comply with the lawful directives of the Board; (c) a breach by Dr. Askarpour of his employment agreement or any written policies of the Company applicable to Dr. Askarpour; (d) any act or omission by Dr. Askarpour constituting dishonesty, fraud or embezzlement, or an intentional violation of Dr. Askarpour's duty of loyalty to the Company under law; (e) Dr. Askarpour's gross negligence in the performance of his duties; or (f) Dr. Askarpour's poor job performance or other improper conduct not otherwise described above, except that cause shall not exist based solely on clauses (e) or (f), unless the Company has given Dr. Askarpour written notice of its intent to terminate his employment for cause, and allowed Dr. Askarpour thirty (30) days to cure such alleged poor job performance or other improper conduct.

------

[**TABLE OF CONTENTS**](#TOC)

For purposes of Dr. Askarpour's employment agreement, "good reason" generally means (a) a material reduction of Dr. Askarpour's duties, responsibilities or authority; (b) a reduction of Dr. Askarpour's base salary; (c) failure or refusal of a successor to the Company to either materially assume the Company's obligations under Dr. Askarpour's employment agreement or enter into a new employment agreement with Dr. Askarpour on terms that are materially similar to those provided under his employment agreement, in any case, in the event of a "change in control"; (d) a relocation of Dr. Askarpour's primary work location that results in an increase in his one-way commute by more than twenty-five (25) miles; or (e) a material breach of Dr. Askarpour's employment agreement by the Company.

As described in the Compensation Discussion and Analysis section above, Mr. Linacre's offer letter provides that if his employment is terminated by the Company without "cause," then, subject to his execution and non-revocation of a release of claims in favor of the Company, the Company will continue to pay Mr. Linacre his base salary at the rate then in effect for a period of six (6) months following his termination date in addition to a pro-rata bonus for the year of termination based on the actual bonus he would have been paid absent such termination. If Mr. Linacre's employment were terminated by the Company without "cause" on September 30, 2022, the total amounts payable to Mr. Linacre would be $0 (as Mr. Linacre would not yet have been employed by the Company for long enough for his benefits to accrue as of such time). For purposes of Mr. Linacre's offer letter, "cause" generally means (a) the indictment or conviction of Mr. Linacre, or plea of guilty or nolo contendere to, a felony or any crime involving moral turpitude or dishonesty; (b) Mr. Linacre's intentional action or an act of fraud, dishonesty or theft affecting the property, reputation, or business of the Company or its affiliates; (c) Mr. Linacre's willful and persistent neglect of his duties and responsibilities; (d) Mr. Linacre's failure or refusal to carry out the lawful directives of the Board; (e) Mr. Linacre's diverting any business opportunity of the Company or its affiliates for his own personal gain; (f) Mr. Linacre's omission of or misrepresentation of a significant fact on his employment application or resume; or (g) Mr. Linacre's misuse of alcohol or drugs affecting his work performance.

As described in the Compensation Discussion and Analysis section above, the Compensation Committee has the authority to accelerate the vesting of Company stock options granted to named executive officers under the 2019 Plan upon a change in control of the Company.

------

[**TABLE OF CONTENTS**](#TOC)

#### SHAREHOLDER PROPOSALS FOR 2024 ANNUAL MEETING AND OTHER MATTERS
Shareholders wishing to submit proposals for inclusion in the proxy statement for the 2024 annual meeting of shareholders must submit such proposals to the Company at 720 Pennsylvania Drive, Exton, PA 19341, Attention: Michael Linacre. In order for the proposal to be included in the proxy statement for the 2023 annual meeting of shareholders, the shareholder submitting the proposal must meet certain eligibility standards and comply with the procedures established by the SEC as set forth in Rule 14a-8 of the Exchange Act.

Pursuant to Rule 14a-4(c)(1), as amended, under the Exchange Act, which governs a company's use of discretionary proxy voting authority for a shareholder proposal which the shareholder has not sought to include in the proxy statement, if a proponent of a proposal fails to notify a company at least 45 days prior to the month and day of mailing of the prior year's proxy statement (or any date specified in an advance notice provision), then the management proxies will be allowed to use their discretionary voting authority when the proposal is raised at the meeting, without any discussion of the matter in the proxy statement. With respect to the Company's 2024 Annual Meeting of Shareholders, if the Company does not receive notice of a shareholder proposal, which the shareholder has not previously sought to include in the proxy statement, by December 31, 2023, the management proxies will be allowed to use their discretionary authority.

The Company's Amended and Restated Bylaws provide that a shareholder proposal (including a shareholder nomination of a director) must meet certain predetermined requirements in order to be considered at an annual meeting of shareholders. In order to be considered, a shareholder's proposal must be made in writing and delivered to, or mailed and received at, the Company's principal executive offices not less than one hundred twenty (120) days nor more than one hundred fifty (150) days prior to the date that the Company's proxy statement was released to shareholders in connection with the previous year's annual meeting of shareholders in the case of an annual meeting that is called for a date that is within thirty (30) days before or after the anniversary date of the immediately preceding annual meeting of shareholders. However, in the case of an annual meeting that is called for a date that is not within thirty (30) days before or after the anniversary date of the immediately preceding annual meeting, proposals must be received not later than the close of business on the tenth (10<sup>th</sup>) day following the day on which notice of the date of the meeting was mailed or public disclosure of the date of the meeting was made, whichever occurs first. The notice to the Secretary must set forth certain information as specified in the Company's Amended and Restated Bylaws. In order to be included in the Company's 2023 Annual Meeting proxy statement any shareholder proposal must be received at the address listed above by October 17, 2023, but not before September 17, 2023, which is 120 days and 150 days, respectively, prior to the anniversary date of the release of this Proxy Statement.

As of the date of this Proxy Statement, the Board knows of no other business which may properly be and is likely to be brought before the Annual Meeting. If a shareholder proposal that was excluded from this Proxy Statement in accordance with Rule 14a-8 of the Exchange Act or the Company's Amended and Restated Bylaws is properly brought before the Annual Meeting, it is intended that the proxy holders will use their discretionary authority to vote the proxies against said proposal. If any other matters should arise at the Annual Meeting, shares of common stock represented by proxies will be voted at the discretion of the proxy holders.

This Proxy Statement contains certain references to the Company's website, website, www.innovative-ss.com. None of the information on the Company's website is incorporated by reference in this Proxy Statement.

By Order of the Board of Directors

/s/ Shahram Askarpour

*President and Chief Executive Officer*, 2023

------

[**TABLE OF CONTENTS**](#TOC)

#### INNOVATIVE SOLUTIONS AND SUPPORT, INC. 720 Pennsylvania Drive Exton, Pennsylvania 19341 610-646-9800

#### THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS PROXY FOR THE APRIL 13, 2023 ANNUAL MEETING OF SHAREHOLDERS
The undersigned hereby appoints Dr. Shahram Askarpour and Mr. Michael Linacre and either of them as proxies, each with power of substitution, and hereby authorizes them to represent the undersigned and to vote, as designated below, all the shares of Common Stock held of record by the undersigned on February 13, 2023 at the Annual Meeting of Shareholders of Innovative Solutions and Support, Inc., to be held on April 13, 2023, and will be conducted on the Internet in a virtual meeting format only beginning at 10:00 a.m., Eastern Daylight Time, or at any adjournment or postponement thereof, upon the matters set forth in the Notice of Annual Meeting of Shareholders and Proxy Statement, receipt of which is hereby acknowledged.

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE AS TO ANY PARTICULAR ITEM, THIS PROXY WILL BE VOTED IN FAVOR OF THE NOMINEES LISTED IN PROPOSAL NO. 2, IN FAVOR OF PROPOSAL NO. 3, FOR THREE YEARS IN PROPOSAL NO. 4 AND IN FAVOR OF PROPOSAL NO. 5, AND PROPOSAL NO. 1. YOU MAY VOTE FOR UP TO 6 NOMINEES TOTAL.

☒

Please mark your votes as in this example.

**1.** Approval of amendment to the Amended and Restated Articles of Incorporation of the Company (the "Charter") in order to amend and restate Section (B)(1)(b) of Article FOURTH of the Charter so as to use a majority, rather than super majority, voting standard and to reduce the list of actions for which a shareholder vote is required:

☐ FOR ☐ AGAINST ☐ ABSTAIN

**2.** Election of each of Messrs. Shahram Askarpour, Winston J. Churchill, Roger A. Carolin, Glen R. Bressner, Stephen L. Belland, and Parizad Olver (Parchi) as directors of the Company for a term of one year:

---

| | | |
|:---|:---|:---|
| Shahram Askarpour | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|
| Stephen L. Belland | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|
| Glen R. Bressner | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|
| Roger A. Carolin | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|
| Winston J. Churchill | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|
| Parizad Olver (Parchi)  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>FOR NOMINEE <br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ <br>WITHHOLD AUTHORITY <br>|

---

**3.** Ratification of the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ended September 30, 2023:

☐ FOR ☐ AGAINST ☐ ABSTAIN

**4.** Advisory vote on the frequency of the say-on-pay vote with respect to compensation of the Company's named executive officers:

☐ THREE YEARS ☐ TWO YEARS ☐ ONE YEAR

5. #### Advisory vote on named executive officer compensation as disclosed in the Proxy Statement:
☐ FOR ☐ AGAINST ☐ ABSTAIN

PLEASE SIGN, DATE AND RETURN THIS PROXY IMMEDIATELY IN THE ENCLOSED POSTAGE-PAID ENVELOPE.

------

**[**TABLE OF CONTENTS**](#TOC)

INNOVATIVE SOLUTIONS AND SUPPORT, INC. 720 Pennsylvania Drive Exton, Pennsylvania 19341 610-646-9800

In their discretion, the proxies are authorized to vote on such other business as may properly come before the meeting or any adjournments thereof.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE NOMINEES LISTED IN PROPOSAL NO. 2, "FOR" PROPOSAL NO. 3, "FOR" THREE YEARS WITH RESPECT TO PROPOSAL NO. 4 AND "FOR" PROPOSAL NO. 5, AND PROPOSAL NO. 1.

THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS SPECIFIED ABOVE. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED IN FAVOR OF THE NOMINEES LISTED IN PROPOSAL NO. 2, IN FAVOR OF PROPOSAL NO. 3, FOR THREE YEARS ON PROPOSAL NO. 4 AND IN FAVOR OF PROPOSAL NO. 5, AND PROPOSAL NO. 1.

Attendance of the undersigned at the meeting, or at any adjournment or postponement thereof, will not be deemed to revoke this proxy, unless the undersigned shall affirmatively indicate at such meeting or session the intention of the undersigned to vote said share(s) in person. If the undersigned hold(s) any of the shares of the Company in a fiduciary, custodial, or joint capacity or capacities, this proxy is signed by the undersigned in every such capacity, as well as individually.

PLEASE MARK, SIGN, DATE, AND RETURN THE PROXY CARD PROMPTLY USING THE ENCLOSED ENVELOPE.

Date:

SIGNATURE

Date:

SIGNATURE (if jointly owned)

Note: Please sign name(s) exactly as appearing hereon. When signing as attorney, executor, administrator, or other fiduciary, please give your full title as such. Joint owners should each sign personally. When signing as a corporation or a partnership, please sign in the name of the entity by an authorized person.

☐

Please check this box if you plan to attend the meeting.

------**

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: px_scan01-bw.jpg]](px_scan01-bw.jpg)

SCAN TOVIEW MATERIALS & VOTE BROADRIDGE CORPORATE ISSUER SOLUTIONS C/O INNOVATIVE SOLUTIONS AND SUPPORT, INC.P.O. BOX 1342 BRENTWOOD, NY 11717 VOTE BY INTERNETBefore The Meeting - Go to www.proxyvote.com or scan the QR Barcode aboveUse the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form.During The Meeting - Go to www.virtualshareholdermeeting.com/ISSC2023You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions.VOTE BY PHONE - 1-800-690-6903Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions.VOTE BY MAILMark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY

11717. TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: D96415-P85798 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY INNOVATIVE SOLUTIONS AND SUPPORT, INC. The Board of Directors recommends you vote FOR the following proposals:1. To approve an amendment to the Amended and Restated Articles of Incorporation of the Company (the "Charter") in order to amend and restate Section (B)(1)(b) of Article For Against Abstain FOUR of the Charter so as to use a majority, rather than!!!super majority, voting standard and to reduce the list of actions for which a shareholder vote is required; For Against Abstain3.Ratification of the appointment of Grant Thornton LLP asthe Company's independent registered public accounting!!!firm for the fiscal year ending September 30, 2023; 2.Election of each of Messrs. Shahram Askarpour, WinstonJ. Churchill, Roger A. Carolin, Glen R. Bressner, Stephen The Board of Directors recommends you vote on THREE YEARS for the following proposal: 1 Year 2 Years 3 Years Abstain L. Belland and Parizad Olver (Parchi) as directors of the Company for a term of one year. ForWithhold 4.An advisory (non-binding) vote on the!frequency of the say-on-pay vote with respectto compensation of the Company's named !!! 2a. Shahram Askarpour 2b. Winston J. Churchill !!executive officers;The Board of Directors recommends you vote FOR the!!following proposal:5.An advisory (non-binding) vote on named executive officer For Against Abstain 2c. Roger A. Carolin 2d. Glen R. Bressner 2e. Stephen L. Belland 2f. Parizad Olver (Parchi) !!compensation as disclosed in the Proxy Statement; and!!!6.To transact any other business that may properly come!!before the meeting.!!!! Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.Signature [PLEASE SIGN WITHIN BOX]DateSignature (Joint Owners)Date

------

[**TABLE OF CONTENTS**](#TOC)

![[MISSING IMAGE: px_scan02-bw.jpg]](px_scan02-bw.jpg)

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:The Notice and Proxy Statement and Form 10-K are available at www.proxyvote.com.D96416-P85798INNOVATIVE SOLUTIONS AND SUPPORT, INC.720 PENNSYLVANIA DRIVE, EXTON, PENNSYLVANIA 19341THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS PROXY FOR THE APRIL 13, 2023 ANNUAL MEETING OF SHAREHOLDERSThe undersigned hereby appoints Mr. Shahram Askarpour and Relland M. Winand and either of them as proxies, each with power of substitution, and hereby authorizes them to represent the undersigned and to vote, as designated on the reverse side, all the shares of Common Stock held of record by the undersigned on February 13, 2023 at the Annual Meeting of Shareholders of Innovative Solutions and Support, Inc., to be held on April 13, 2023, and will be conducted on the Internet in a virtual meeting format only beginning at 10:00 a.m. local time, or at any adjournment or postponement thereof, upon the matters set forth in the Notice of Annual Meeting of Shareholders and Proxy Statement, receipt of which is hereby acknowledged.THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE

UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE AS TO ANY PARTICULAR ITEM, THIS PROXY WILL BE VOTED IN FAVOR OF THE NOMINEES LISTED IN PROPOSAL NO. 2, IN FAVOR OF PROPOSAL NO. 3, FOR THREE YEARS IN PROPOSAL NO. 4 AND IN FAVOR OF PROPOSAL NO. 5, AND PROPOSAL NO. 1.PLEASE SIGN, DATE AND RETURN THIS PROXY CARD IMMEDIATELY IN THE ENCLOSED POSTAGE-PAID ENVELOPE.

------